Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Chromobacterium violaceum ATCC 12472, ATCC 12472

>CV0826 hypothetical protein
MLVYYSLRQFWRHMRYTKPVQRGIDPVGEAEVFLAYGRTREAVRVLKDSL
KDDPDNLHAKVALLRAYSNARDSKAYVSLARDVHPQVQGQPVWHTIRENG
RELAPQEPLFSKR
>CV1145 conserved hypothetical protein
MPRRNAETDDDDKPVPLYRQYETQGTVRQISFYLSEEIGAAIHYTDLLYT
LRTASSTDIVYLHLNTPGGNFDAGLQIINNITASQAHVVTILEARAYSMG
ALIFLAGDELVVHDTCQLMFHNYSSALIGKGNEQQAQVAASGKWFEKVMR
HVCRPFLTDEELDRILKGEDIWLDSDGIRRRLNNIQKGAPAVTARKPGKK
GGAAEPRG
>CV1734 probable outer membrane protein
MWCVLLFLSFGGQWVHATANDFLQLLQRASYSHPQVAMAQSQREGADGER
QAARWQRYPMPSFQSVTPQDRSRSEPVNRFSLEQPIFAGGRIDAGIDEAE
AKYTASEGNLDQVAVDLGVRLSTVWYEWHRQRERKMVLMDSVQAHQRLRD
QISRRVKEGVSAQADLTLAVARLSQAEGDLQQAKSAERNLYAQLVQLAGA
QIHYLSTFPVPSADQRVREAPSVDWREKAIARAPGLAKLDAEADAAAAEI
RVKRGQLSPVVSVRYDYDASGFRKGSGVFLQVSAQPGAGLSGLSGVKASE
AYYQAAKDARRSAELELRQMLDTDFSDYDSALGRIQSYEQLQISSREVAA
SYARQFVAGRKSWLDVLNAVRESVAADLSIIDAKTQRSQAWWRLRLRAFG
LGEISKEPQ
>CV0484 probable type IV prepilin
MGVREDGGFTLVEMMVTIAVAVLLLTVAMPAWQVFVQNERLNSTRDQLIS
AMNQARSLSISNDDVVTICPYNAGSASSCGTSWSAGWAIFELPQGGASSV
RVQAQPLTLGSSPTINAATSGGASLSSISFNPRPPYVAVGQTGDFRLCDS
RGASYALSFNLQTTGYIQQPAKAGVTLAGAALTCP
>CV2594 probable type III secretion protein
MTLLSLPITKLPGNAPLGPIIPAGDLADYIEASEIIEQAREQAKSIIQDG
EKKIENLCEMYEEISEAAWQDGLKNLEQQAPALRQQAVANVVEWLIAEQE
LEHKIIERLEGQLCDILIKVFKEYYGQQNESQLLINLLRERVRALLDSEE
GVLYVCPEQYEELKQALISFPKLLIESDASIMAGKALLQTPLVILSLSLN
EQFDWAISRLFSHSHEMWQERLLDCNIPQQGELSLFPKDFIEARGGNFMS
VSASLGSAAEPVVDSSQG
>CV4365 probable multiple antibiotic resistance protein marC
MFKTLSLQFLFGGLLSLITITNPLSKIPLFITLTREMSDSHRDSQARRAC
VFAAAIMAVSLLAGNLIMAAFGISYGALRIAGGFVVAVLGYRMLFLSQDP
GQAPRQSGEREDYAFFPLAMPGISGPGTIAVVIGISTEIAELSTLPAKAL
AFAMTFAAIGLTCVGMWLTLKSSLLISERLGRGGREVMTRLMGFLLICIG
VQFVGSGIRTFMAGS
>CV2927 conserved hypothetical protein
MSQLTFWFGCALVALIAEFVSGTFYLLMVALALACGGFAAWLGAPEPWQW
LIASVSGAVGLLAIHRRRRSLMPPPPPQDDPDWGQQVEIRALTTPGHARI
HYRGAEWDALLMDSRLDAGSTGYISGREGNLFKISSQQPQ
>CV0710 probable outer membrane multidrug resistance lipoprotein
MRTAYFRWRPLPAAGLSAALTLLGGCAMTPDMGPAPQIKPLQQYQNTQSL
PASDGVWANEQWWKKYGDAQLNALMDEALSQAPDLAAARARVERAEGLAQ
QAGAARLPGADLNAAIDRDKQSYNNGMPAPAGFNTSGRATLDFSYELDFW
GKNRASLAAATSDLTAARADAAQARLMLTASLAAGYAELARLFSERDAAA
QALEVRAHTAKLMLQRWQQGMDTRGVLRQAESREAAARADLAAADESIAL
QRHSLAALIGAGPDRGLAIARPAAGLFREQRLPATLAAELLGRRPDLAAA
RLRAEAAAKRIDVAQAQFYPNVNLTAFVGAQSLGLGLFDKAGSGIAGVGP
AIHLPIFRGGQLQGQYRAARGDYDAAVASYDATLSQALREVADAVSSQAA
LTPQLQQRQQALTAADEAYRVSRNRFDGGLANYLDVLTAEDSVIAARRGL
ASLQARRFSLDVALVKALGGGYQAAEPAR
>CV0482 conserved hypothetical protein
MSRTSLNTTWVYYMSPPGGFGFTSSPTATSTTDTVLNPCYGYLSLGTSLS
TVKSNCASVASSLGLSGTTVNGSQYMTVAATSDDASINDVLYSSGLNPVF
MTYGTVSPSNPYSYYSLNSYKTGSVTVSYSLMAPGGFSGWGTSPTNAGYV
PFTPQVLYAQRGWGYGGSQSYSAAATNVAMTNLGSPSASQLTSAYNSFSP
FLQPETNSTSTSEIKAAAGQSPIYALLKTAQTSFTSTSSSSGCTPQKYVV
LITDGLPTQDKSGYYWPPAGSAAATGYGVTASFNADGSLNIAGTNDQALL
DAISQIQTLASAGIKTYVIGLGAGVAPATNPTAAQTLTAMAVAGNTGSYY
PAVSPAAFSSALGSILVQIQKGSYDQASVALNSTTLSTNTQAFLASFNPS
DTPYSDWTGDLAAYALGTSGGLNVSTSASWSAQTQVDAFASGSGWQNTRL
IATWDAVNNKGVPFRWPATGVIGINSTQQSQLQPSDTKGSLRVNYLRGDA
SQEARNGGAFRNRSHLLGDIVDSGPVYVAKPDGPYIDSSYQTFISNNANR
TPMLYVGANDGMVHAFNASTGNEAFAFVPNGVFANLYQLTSTSYNSNHIY
FVDGSPQAGDVMFADGSWHSVLAGGLGGGGKTIYALDVTSPSSLTSETAL
ANAALWEFSDSGMGYSFGRPTIARLNGSNAFAVLFGNGYASSGNHAIFYA
VNPQTGATLAKIDLCSSVPAACSSSAPQGLSEVVAVNSSGNAGAAVDTVY
AGDLQGNLWAINVSSANPANWSVRLLFTATDSSGNHQPITSAPAATLNPN
FPKQKGMMVFFGTGQLLAQSDLTNTNTQAFYAIYDNMTITSLTPSNLLQQ
TETAITTSVSGFPSTTVSSSLYNWQSPNPPLNCVVGRTCPTLYGWYYTLS
FAGSGSRMLTNPQLFAGNVVYTTFSPSATPCTAGGSSFLMSSNYATGGPP
SQPFLDANGDGLVNSSDVYNQQPLSGVQLGSFFASTPAFVVSNQGGYTAS
ILVGGGNSSSRNNCANGKLSCTSSSPSQQYYSWSGWWQIL
>CV2703 probable outer membrane protein
MLKTWPWLALALLLAGCQATPYQRQALQTPAQWTKQGEADQDMGREAWWG
GFGDPALLEVLQRARKRNPDLEIALLKLRKAQLEAGLADGDARPTLSGSL
SGNRIRSLDGGGWSRSHSEGLKVAYEVDLWGRVDAARRAAGEAFVASRYD
QISAGLLSDSTAAGLYWDIAAGKAKLILGQAALVDAGRAQALARSKWKAG
ALAEQDVTQADNAALEQRANLLSLREQLRKKENALALLLDGPPGAALPDI
QPLVARPGMPNVAAGQPGELLRRRPDLQAAEARLRGKLADVDQQRANFFP
RFNLGGDLSRSAAVSGEQLGFGATLTLPFLNWRQLNLKLKSSEVEYQLAE
VEFRKTLYIAYREVEDGLYEWRRLGESAALQDEAVVLAGRNATLAESRYR
GGEADMQSWLDAERGKREAEGKRLELSLERLKNLAVLYKALGGGAVEAGV
GGGWE
>CV3806 probable general secretion pathway protein L
MRPGWPDSEPGLPWALLGARGELSAQGDSAPGGWPKAEQCELVLPAGRTL
FTDVKLPDAVKQPTPAVIGFALEEGLANDPGANLYALGEALPGGRRAVAA
TEAAGLRRAVAMLKSLGRLCDRIVPEECLLSPPPAGGWSVTRLSDRWLVR
AAAPYAASLPRGGGQQEQALFASLLSTAMPARLQLCGVDSAEEVLARLPG
WQGETARGEACDWRSARRHGGYDFAQGDLAANRYWRDWAPSLKKTGWLLG
GLLAAQILLTLGQSGWYAWQKHSLSQQIRAAATPWIGGQAQPGSSALAMT
RAVDRLRLSHGLPARDDLVELMGALAAVSGRELQVRTLEYEAGRLKLQVA
EVPAESLARWRKQLAARQIMLDATSSQPGSKQLVVAREP
>CV3875 probable flagellar protein FliS
MLNSRMLKQFNQAYANDALKTAIYGASPVGIVVMLYEGAIKALQAADTAI
DNSRFDEKARMITKAVDILEGLRIALDLEQGSEAAVNLNDLYLYMKLRLA
KASLKNDKEILAEVRSLLETLLPAWQQVNRAGAAQAAGVEPQAGA
>CV0707 hypothetical protein
MKHSINRLALAIAAALASQAAATAPLQPIRNHAFAQSCQALWGKETARSR
WVKDDGQGGLAYAPLNGNGDHIMDFSSAGYMGGGVALPTAPVKATVKPSG
KAADDLANIQAAIAKVAALPAVNGVRGAVLLAPGVFLLEAPIQLASDGVV
LRGSGSGAGGTVLKAQGAGHAMLSLGGAGASLTPIGSAAAIADGYLPSGG
SVIHVSNPSGFKPGDAVMIRRRASAEWIHVMDMDQLVRDGKPQTWINAGN
NNEIWLRTVAAVSGNQLTLDIPLSDSFDSGYLGTNGGSVQKYAASGIASQ
IGAERLALEGLPNGSGADYGVANLDNLSDGWLNDIQAHNFTNGVVVGKQG
RRLTLEQVALSHDHNHVDCSGAKAFEFSIAGSQVLVDRSSSIGGKKSFYY
ATQAQAGGPNVLLNFTGRAEACGNIEPHQRWATGLLVDNADISGAIALGN
RGADGSGHGWSIGWGVAWNAKADQLAIAAPPGATNWAIGSSGALTPDVPD
AQGVPVPPKLGSVDSANVRVGPDSLYLMQLCQRLGPQAVKNIGY
>CV3540 probable fimbrial biogenesis and twitching motility protein
MDADHRGQEIMTSWRGRLAGWLLAFGVIAPAAADGSNPSEVARIRSQLAV
EYSRIGNLKSALDNANQAVQADPAYITGYLSRAYVLGLLQMDDKAEQDYQ
QALKLDPANPQVNNNYGLFLCEHGRPQDSLALFQKALANPLYDSPQSAYL
NLGRCSAKLGRTDQANDYLLSALRVAPNYAPALSELAEMQLGLGNAKLAA
FYFERLRSGGGMNGLGAAELWLGARIARKTGNAALERACGNELKNRFPDS
RETQLLLSGS
>CV3002 probable flagellar motor switch protein
MELNQDFDLDGILDGLDADAPSPAPAESAPAPRDMTPFLRKIPVKLTLEV
GSADISLADLCQISAGSVVELDKIAGEPLDIKVNGTVIGRAEVVVSGDNY
GLRVVELNDLQLDSLA
>CV3814 probable type II secretion system protein
MRISKLVVALSLIYSCNLLAAPQNDTVMLNFVNADIETVVKAIGEISGKN
FIIDPRVKGTVNIVSSRPVPRALSYQVLLSSLRLQGFSAVEGNGVIKIVP
EADAKLHAKASKRIPRGDGDRLITKVFALRNSNANQLVPVIRPLVSPNNT
VAAYPQANALIVTDYADNIQRIESIIESVESAAAGDTVVIPVLFGSAVEL
ANSLNKLMQEGGADGGKTTILADARANVLLVRADTPGKIGKVKSLLKVLD
QPSQAGSNVRVVYLKNAQASEVAKTLRLLLASEGSPVQTRSTINTATSTG
GSASLMPSTTGSGSGASAQNPVSSPDAGAAVAASSSSAPSGAGVGTMIQA
DSNSNALILNVPDPMYQNLRNVIDLLDKRRAQVYVEALVMEVTASRATKI
GVQWAANVHGNGLIGNSLPSPSKPLVPGGSGASDTPGTALGSLVSSLTGG
GLTAAIINTITVGGQQIPTLGLLAQALEQEAQGNLVASPQLVTMDNEKAK
IVIGQEIGVPTATYPAGTNGTSNAPYSTYDRKTVGFGLEITPQISEGGTI
RMKISQAADSIDQTTLSAAAGPTFNRRTLDTVVTVGDGGLVALGGLTQET
TSNAEDKVPLLGDIPVIGNLFKYQGKERKKTNLMIFIRPTIIRDEIGNRA
VAGERYGYVMEDAARNVGRKLPLGLNDQLKTPAAGSIHGALNALDTLNKS
EDNTKAKQ
>CV2912 hypothetical protein
MTESPKANEPDWSGLNLPVLTEVVDEQAVPTLAEEAPPAEVPEFDFSSEL
DLLAAELDEGETELEIPELTLDELLEAPTPAEPAGGLDFSNLPSLELADA
DGSVDGEGLDFVLEPKAEAAVQDADGLAALMARADLHPAVSESEPLEPAA
ETPSEPEMPEAVSWNDVVAAASELQADSLPALDSDAQAAAPAGLPEPEGV
SEAAPPPVEMGPALSPAEPGGADLPPEPPVSAAQASGAAGAESEREEAAP
FTSISIDSLPSGVLGGGVGREPAPPSGLEWLSELPSQQAEPPKPSIKDMI
AEAERVLAEERAKQAAANLAAVEAFGTRPAEPPPAAPEPAAAPASEEIQP
LAETAVSGFDEASPVAEAPVGPAAETAQVPEPESLPDFAAAAELEAPASI
DSAEIELPDGHGEAPAERMEAMSETAPETGPREPEAETGPMAEEAEPAIV
LDWPALIERDVEAQPASLTEAAPAAEPERQDGAPPPFPPEAGDASLPESA
EDASAPACESEPVAAFDSIDGGAVEADGAMNGEPSVLEDAAESAPARLPE
RLEPLQPEPSACGAQEQALLLDEAAPAETREPDPAAAPQGDELPSLEEEA
EPAAGEDAAPAFGQADALLEGEEDAAALPDAAFDSEREPAMAPEALAGLA
AEPHAAEIEPFDALPEHDQPDESVEERPEAAFAPPEPDFDAAFEGHQAEE
PQAGEALPAEALSASIPVLPVAEAAVPDIQPEPEAKPLVEEDAVSTLYEA
VPQPAPLEDEDMPALSGLLGRGLAAPAVSTPLAEPVAEPSASVDSAAEVS
VLKVAAMTSAAAAGASRQSPQGLDEQALFDSLYEQMLPRMKVELSLWLQD
AIEVQAKQMLSGMMHQLKEDYEMLFGDALKESLRQALSDAGRRDGEGGHE
>CV3348 probable exbB-like biopolymer transport
MWAIVEAAGWPIWTIIAASVVSLAIILERLYTLRRGAAVPQGLLAQTLQE
YRRVGDKEELLQRLQGHSPLGRLFAAGLRNVHGSREVMKEAIEDEGRQVA
YQLERLLTTLGTIAAMAPLLGLLGTVIGMIEIFGSQNASGANPQQLAHGI
SVALYNTAFGLIVAIPSMMFYRYFRSKVDGLLVEMEAQAVKLVEVAHGER
KNGS
>CV3127 probable flagellar biosynthetic protein fliP
MKKKIVIALLSGGALLSPLLADAAAGLPLMTSTPAAGGGQNYSLSLQMLL
FMTALTFIPAMMLMMTAFTRIVIVLSLLRQALGTTQSPPNQVIVGLALFL
TLFVMGPTFDQVYAKAWVPFSDDKISFNQALDEGSKPMKAFMLRQTREKD
LAFFIEISQSPKPQSKEEVSMKTLIPAFAVSELKTAFQIGFMIFIPFMII
DLVVASILMAMGMMMVSPVTISLPFKMMLFVLVDGWTLLMGSLVQSFYTG
>CV1469 conserved hypothetical protein
MTASGLTLSNGTGLASDYALQSNTAATTANINQAHLTISGLAASDKTYDG
TTGVTITNWGNLNGLVSGETLTLNHGNATFGSAASNAGTLTVTASGYSLA
NGSGKASNYILDTPTATTQAAINKALLTITANNDAKIVTQADNAGSYNGV
SYSGFVNGETASVLTGSLSVSRSGMGAGNGVGDPAGSYANSLVASGLSAA
NYAIAYQPGNYTIVPANVLLVKAANVSQAYGSAFNLAPPTAQYLDGASNL
IKTLTVTANGGNNFSASDGAGGSVTFTLAPSGGAYSGSNNLSLGNYNLAS
SNAHITGSNFNSLVYTGVETVTPKALTPSAISGVSKTYDATTAMNGLSLA
GGSGLITGDAVTISGSGAFASANAGSEGYTVNNLTLSGHDAADYYVTNAG
TLTGTGTINARHITLNAQSDAKTYDGTTSSTQNVAIGGSGLVGSDSISGL
AEQFNSKNALGANGSTLSVKAGYAVNDGNGGNNYIVDALNTASGTINKAA
LTLSAQKDVKTYDGTASSSGTVLLTGGLVGGDSFSTLSQSFDSKNAGSRT
LNVNYAINDGNGGNNYQVATLAASGAIAQKILTAPSLSINNKVYDGTTSA
SINASGGALNGVLGGDSVNIDTSRGVASFSTKNVGANLAVTIGSVGLSGA
DAGNYTINNIATARANITPLAITVGATGQNKIYDGTVNDTVTLSSSGVLA
GDAVNFADTSATFANKNVGNGKTVTVTGITASGSDAGNYTLNNGTAITSA
SITPRTLTVSATGQNKIYDGTVNDAVTLASSGVLPGDIVTISAAGASFLD
KNVGKDKIVTVAGISASGADAGNYAIANSVTTTASVTPITLYYFSQAQGI
KQGQTPNGLSGEIRGNFASGENLSNATDGTLRWTTNGNAYSAVGQYAIMG
SGLSAQNYIFIQDPSNATALTISPNQVPFITQTQNDVTAQILALAANGQA
SSTPYGLTTKPFATGNVAANRKYHGDNNTGLSGFETVLNLDVIDGGVKLS
TDRKTLGGGN
>CV1468 probable activation/secretion signal peptide protein
MTSRSKPYFLAKTKSSNMHPRKSGTLHSVHMISYALLAIWTVQAGAANPS
VNIDSGQLLQELKRPKPTTPIKDTPLTTELPVDVTKQSGGTLLVQDIVLE
GNTVFDNKTLLELVADAKGKELNLDQLKELATRITHYYQQHGYPISLAYI
PAQTPSDGTVKINIIETRFGEITINNQSSVKDKALLANLKPLQSGDLVRE
DPLQRSLLLLSDTPGIAVHSVLRPGANPGTSDLQVSAQAGAKFAGSVLLD
NTGNTYTGRLRLGGTLQINNPLNQGDQLVVNGLTSSGLSYGRVDYQFPLA
GQATLLGGAASYLDYKLQNDFSNLGAHGNASEADLWLSHFFVRSVNGSLI
GRLTVNQKNLDDNIDSNQSNKNRRTNNVIVELSGDRLDSHGISNMRLALT
SGELKFRNEAANLLDTESAKTAGHFFKSTLSLARLQRLTNSSALYLSITG
QLANKNLDSSEQFVLGGFNNIRAYESGAAAGAEGYAATVELRQNFSLPAP
GTWQGIAFIDSGRVQLYKNAFASGENSATLSGVGIGLNWSGGQGWNLSSI
LAKKIGSSPPASIVSNQKRALFWLQLNKQF
>CV1737 conserved hypothetical protein
MAAEEHVVSGAQNEVVAQADASSASSVVSNAGQVDPSASASHEVVAGKTG
YSPWLLGTALVGGLAAAAGGGGGGGGSSGSSSNGGNGGGPAPQPTAQFKG
TVIDGYIKGADVFLVDRNGKEIATGQKTDDKGNFSINNPNGLAVKITGGV
NVDTGAANTLELYAPAGQSGKVMVTPLTTLVHKLVTAHGMSNADAKAQVQ
KALSLKGDADLLTQDPIEAKNLEAHKAAVKVAIVIAGIGAGSAATDKVLA
DLVASIKSNSLQDLNQTLKTLVEQHVGSEKSATVELQMKAIDAAADFQKI
SESQKVIAGDTTPPEKAHIDVTTLVGAEAAKSPLTLKVKAASDAETVVVK
FNGQVLVADGKGAYSIDASKLDDGDYKVEVISADKAGNASISSQTITIDT
TAPVVEIQALGGQAGFSKGFTVNAGAVVTGVDLAKFDKTSKDGIDTYIAK
AGAFKGDEALKLDASLIDAAGNEGKAGLELKIDTIAPAVPTIALKVDSGT
VGDKITNDATLEISPATDGVGRVFKVDGVQTSGYDAGKLAEGKHTVEVID
TDAAGNSVSSGEFVFDLAKTAPVVALKTITGEGGFSHGFTVNAGAVVTGV
DLAKFDKTSKDGIDTYIAKAGAFKGDEALKLDASLIDGAGNEGKAGLELK
IDTIAPAVPTIALKVDSGSVGDKITNDATLEISPAADGVGRVYKVDGVQT
SGYDAGKLADGKHTVEVIDTDAAGNSVSSGEFVFDLAKTAPVVALKAITG
EGGFSHGFTVNTDAVVTGVDLAKFDKTSKDGIDTYIAKAGAFKGDEALKL
DASLIDAAGNEGKAGLELKIDTIVPAQPTVALKVDSGIAGDRLTNEATLD
ISSAADGVSRVIKVDGVKVDGYYGGELTEGKHTVEVVDTDVAGNSVSSGE
FAFELDRTAPVVTLETIYREAGFYSGFTVTAGAVVAGVDLAKFDKTSKNG
VDTYIAKVGEFKGDEVLKLSASLKDAAGNEGKSRDVELKIDSTVPAQPTI
ALKVDSGIAGDQLTNDATLNISETAAGVTRVIKLDGFKLDYYNPNHMDHY
DPSKLTDGLHKVEVIDTNAVGNSISSGEFSFVLDKTPPKWPLLKLVEDTG
TKGDNITRNGEYTVSAEDGVRVEYKVYGDAEWHANKPVAVEGRNYTNIIM
ARAVDKAGNVSDETELKFTLVTTPPPKPSLLIDVSNNIVDDPLLTNKNLH
GISSAYWAEYSVDGKRWTHLEQNAGASYLGSAEGVNHFYARATDEAGNVS
EIGEYTFTKDTIPPAPAEINIDPLINGDRAKSPFSFTVKNPDDVVKTLVS
FSGMGFGDFAANSDVNGSYVIDPKGLINGVYKIQVLSYDKAGNKTVSYKD
FTLDTITPHIFLVHDTGRSAVDGITSDGYFDVTAMPELGATFSYSSDGGL
TWSQYKPDAVEGLNVIKVIARPEAGGASSAAELRFILDTHAPDVPTIALK
VDSGIVGDKITNDAALEFSKLEDGATRVIKLDHVKVDGYDPGKLGEGKHT
IEVIDTDAAGNSASSGEFTFELDKPAPLLDIRALYLDGQVDYSKGFSVTT
GATVTGVNLAKFDKSSHDGLDFYIAKNNAFNGEILLANASLTDAAGNESK
AFQRFKVDTTPPDVRVTPLNPHNGFSDGFIVPAGAEVSGVDLKDFYKTTE
MDSPDYYGGADVYRPSTIKFNDEMVTVVARLKDQVGNVGQAELTIKIDNV
PPTLELRAIPHKGSYSSGFTVTKDAEVDGPLDKFDKTVDSTGQLYIYTAK
AGAFDGESPIISASLKDAAGNVAKATIQPKIDTTAPHTSGIYSVGGRAIA
HGFGVDAGAEVIGVDLTKFVKSFDGAKQWDIYTARDGAFNGELVAVNVRQ
VDGAGNASDTTSGSLRIDTQAPDAPGFTFAAGNSINFVAEEHASLWYSVD
GIQWDGVKPLILPFKPQFGSYLAHQVDEGGNVSAAVKTFYSTTTQADQFD
IQKADPASKVVLKFNKTMDHIHLEGLAVTADTDLSGKVSAEQAGGDVKLT
FAQDSGFAGSLVLHNVTLTPEELHKPNVLFV
>CV2848 probable outer membrane component of multidrug efflux pump
MSALVLAGALAGCAAVGPDYHLPSQAALGKPAANAAFLSASAPAFAQQPV
PAGWWRLYDDARLDTLVAEALAANADIRAAAANLRKALAVEASVNAERDP
HASVSAAVQRAQDSGEAYLIEKKLPVANVGDGGLKIGYEIDLFGKLARAE
EAARAGTQASEAAMDLARTTVAAETVRAYVQGCAAGHQLAVAKHELDLQN
RGVAVAKRMQSAGRGRATDVERAQAQADIQRAALPRLQAEQDAARFRLAA
LLGKTPAELPAAACSDLPRLKRPLPVGDGAALLKRRPDVRAAERKLAAAT
ARIGVAAAQLYPSVSLGASAGVTGLLEHAGEDRTRRWSLGPLISWTIPDS
GARARVKAAEAEADAALAHFDGVVLNALRETETALTFYAKDLERNADLRS
ARDNARAAAQDNRRLYAAGRAPYLASLDADRALAGNESALAASDAQVALD
QVNLFLALGGGWEQIPR
>CV3838 probable outer membrane drug efflux lipoprotein
MRALPLLLAAALSGCAAVGPDYRPPASELPAQWKSDAGWLPAAPADALPK
RDWWRMFGDEGLNRLEADALARSPTLQLALARLDQAQAQSRIRGAAALPA
ASLGAAASRSRVSADRPLSSYGASNASAVQSDLKPMLSVSYEIDWLGRVR
RDIESARAGAEQAASDRANVELLLTAQLASAYLQLRQEDEEIRLLDGILD
AQQRVLELTRIRHLAGLASAGDEAQQAAASAASRAQRELLLNQRRANEDL
LATLSGAPAPSFRLASGSLPAALPALPNGAPSDLLQRRPDIASAERAMAA
ANAQIGVAKAAYFPQLTLAPTYLGSESTGLGKLFSTPALIWGVGLQATQT
LFDNGKARAGVDYAAAGYRAALAAYRQTVLQALQEAQDALGSLHGLDQAR
RQQDEAARNQDKAYAVIQLRYREGLDSALTLASARQSQLAAQRTLAQLRG
AQLAASVSLLKALGGGWQAPFPRQPF
>CV0837 conserved hypothetical protein
MKTYQQKQAPVKGQIAPPPLFKITSLAVAAAFCVPQQAHAACSGSSTVSC
TGSLSGSLSYGSGTSEIDLVNANLSGTVTWNNPTGPSVITISGSTLSTNT
GQAFSVNNANGALSMSLDAASQITSPNSGSGAVSLTTSTSNTGDILLNSA
ASVSGKGGLLTWNNGSGSITMSNSGSVVSNNQSGLGATTAAGGSISITNA
SGGQTQASNGNAIDTHSNGASGDTVIVNNGSAISTGNASGINSTSNGGNI
AIQNNGQVVAGGTAITASNTGAGNITINSSGTINQAGTAAAAIGVNSNGG
QVGIDTRAGSVNGSIFVTANNGGVQATVGNIASNSNAVVVTYTGSNANAG
GVSLNTAAGTDISTSFAGIAVTSQGNNGGISVTTNGTIGGAQAVRNGVIG
SITASGNNANVQMQLNNTVNAVRTAIAGSTAGNGNVAIVSQAALSSQQGH
GISASSAGGNVSVTANGAVTGVTAIRGSSASGNVALTANANTTGTGAVAL
SGNQLSGAALQVANAVQATVDNYASATTQSVSVAAVDVNAGSAIVNNHAG
ALLAGAGDFAVNGRNGNVTVNNDGTITGYVTLQGSGNTFNNNSSHSLDLR
NYVAGVQNVAVAQINGVFNNNADGVLRVLAVNAPQSVNNAGAWQTGGSQL
PGNGVVQGQLTGVSNFNNSGTITLQSADIGAAQAVAGKLLVITGGQTAGA
SGGGTYTSNGGQLRLDAVLNQGGAASLNDMLVVDRTAVGSGGATRVSVNN
VGGLGGYTGNGPSDGIELIKVLDAGYSAANAFSLAAPLGAGAFQYSLRQA
DGQNWYLQTTDLVPLAKIQAMLPVALSQYGLDTLGTLWQRVGSRRYQPQQ
QEEAGRPAAWVRAGGHRGYTEGSIAGNGFSYASSYQLNDDFIEIGADHRL
WQSGKGSWIGSLFGSHGNGSMKLQNGADGRADLSSNSLGLAATWYGNNGY
YLDMLGKWSRIGTRLAATGVNGSPDGHSALFSLETGYQRAISRDWSVVPQ
LQLVWQDNRLDGYTDSNGVKQQADNDRNLMGRLGVAMRYAKPEAEGRGFN
GYVKADLLHSFQNSGLVTFSGTPLAFQSSRNSMELGVGGNWSNAKRTVDT
YVELNYRHALGGNAGYTAGGMLGARYHW
>CV0413 conserved hypothetical protein
MDLARLERQHRQLEATLGRLTRQHDAWQASLRRGRALSIAPGGALQSTLR
IQQSRIEVMASVRLSASIRMVEQKLESQRRDQDKAERNLPPAGEPRSGAR
GGQGTGSKSGNRSGGNDAGDAPAKRSSVSSPSSPPSGWRWPSIDLSLGKL
RLPTRQELIRVADFAQKAGAAVANASGKAHAALSTGQGRKTLDFVHGKLD
KALGGRLPSVDKILGGLKTAETVGQVVSKTGQLAGVTLRSLDGVKWSDLK
PGNAGKSLTGAADYAKRGGAVIADASGRLHAALSKGEGREALDFVHGKLD
KALGGKLPSVEKILDGLKTAETVGQVVSKTGQLAGVTLRSLDGVKWSDLK
PGNASKSLTGAADYAKRGGAVIADASGRLHAALSKGEGREALDFVHGKLD
KALGGKLPSVDKILGGLKTAETVGQVVSKTGQLAGVTLRSLDGVKWSDLK
PGNAGKSLTGAADYAKRGGAVIADASGRLHAALSKGEGREALDFVHGKLD
KALGGKLPSIDKILDGLKTAETVGQVVSKTGQLAGVTLRSLDGVKWSDLK
PGNAGKSLTGAADYAKRGGAVIADASGKLRAALSKGEGREALDYVHGKLN
AKLGGVLPSVDSILGGLGQLEELGKTVSKAGGMAGKALRAYAGASGNVFQ
KTMAAAGTLLGGDEADGGSQAGGKSGKGKKRPAAKPAPKTAARTATKTAP
KSGAAARPPSKAKAESPAKPKAAAKPVPKPKPAAKLAAKPGNALKNARGL
LDKGKNALSGLKPGKSGGGLLKTGLQALGKGGKGLKSVIGKADLLGVGMD
LLFTSQSNLSPQAKAAAYGKTLGGTAGALAGGAAGAAIGTMLLPGVGTFV
GRQVGSWLGQKGGEWLGEKIGNWAGKPSAAPKPAGVPKPVTPPKPVALPK
PAAQAKPVPKPAAKPAAQAQQAQQLQRIQQAANKAAAKPTGPAAAFNITF
SPQITVNGASAAGVKQQAQQAMQLSFAEFERMMKRYEADRQRRSYAARG
>CV0684 hypothetical protein
MRIMQLLWLSSCLGHAAAHAEQAVIDNSGQSVHGIVALNQAAGSANQQGN
LQALAVSATASHANVFLFRQQSATSTAGTADAHASIAGAAFSGSQGLMAI
NQTAGHANHSLNAFTLAASPQPQATTLPSSAADSLLAGTAGSNPAMAAGS
SGRHDQTDISAAAFLGSRGLVQLNQIAGSHNQAVNVVAVQWAKP
>CV3808 conserved hypothetical protein
MSARRQGGMTLLEILVAMSLLAILSVMGYKAFGSLLIARERLMQTGEQWV
DVARAFRRLESDLSGQQPAANAAEQQQGLTLGASSLVLQQDGKGQALVLE
AVSTRYPSGRERIVYQSGEGGVSWSAGEAGAASPVVYALLGRDMRVDWRV
LLNDGSWQQAWPMGDAAQGRVPRALEMRVQMPGKRQARRIWVLP
>CV2871 probable hemagglutinin
MIGGQGVDLTVSDQLHNDGVVGSDGQVKLSAGTLENAAGTIQSGKDLQLT
ASSLTNADKGQILALGKDTASKVDVSGELHNQGKVAGNADLTVNAATIDN
AKGTLQAAAGLNLTKQTSLTNDGGHIASQSLKLNADSLSNQAGEIYAQQQ
LTSQLKSLDNRQGSLIGGQGVDLTVSDQLHNDGVVGSDGQVKLSVGTLEN
AAGTIQSGKDLQLSASSLTNAEKGQILALGKDAASKVDVSGELHNQGKIA
GNADLTVNAASIDNSKGTLQAASHLELSKQSSLINDGGHIAGQSLKLNAD
SLSNQAGEIYAQQQLTSQLKSLDNRQGSLIGGQGVDLTVSDQLHNDGVVG
SDGQVKLSAGTLENAAGTIQSGKDLQLTASSLTNADKGQILALGKDTASK
VDVSGELHNQGKVAGNADLTVNAATIDNAKGTLQAAAGLNLTKQSSLIND
GGHITSQSLKLNADSLSNQAGEIYAQQQLTSQLKTLDNAKGSVIGGQGVD
LTVTDRLHNDGVVGSDGQVKLSAGTLENAAGTIQSGKDLQLTAASLTNAD
KGQILALGKDAASKVDVSGELHNQGKVAGNADLTVNAASIDNSKGTLQAA
AGLNLTKQSSLINDGGHITSQSLKLNADSLSNQAGEIYAQQQLSSQLKTL
DNAKGSVIGGQGVDLTVTDQLHNDGVVGSDGQVKLSVGTLENAAGTIQSG
KDLQLSASSLTNAEKGQILALGKDAASKVDVSGELHNQGKLAGNADLTVN
AATIDNAKGTLQAANHLELSKQSSLTNDGGHIAGQSLKLNADSLSNKAGE
IYAQGQLISQLKMLDNSQGSLVGSQGVDLMVTGTLHNDGTLGSDGQVKLS
AGELDNATGTIQSGKDLQLTAQSLSNADKGQILALGKDAASTLTVSNDLH
NQGKIAGNGQLDVNAAAVDNSKGTLQAAGTLNLTKQASLTNDGGHLAAQS
VKLKADSLSNQAGSIYAQSQLTAQLGTLDNTNGSLAGEQGLNLGVQGRLH
NDGSLGSDGQVILAAGALDNGAGTIVAGKDLQLTTSTLANANKGQILVQG
QDDASAVRVDGQLSNQGKILAASDLKVQAGALDNSQGTLQSVKALTVDAQ
KTLANTGGHIAGQSLSVSSDALNNQAGELYSQQALDGRFRQLGNSQGSVV
GGQHLALNVKEGLNNGGMLGSGGQVQLTVGQQLDNGNGTIQAGQDLQVTA
DSLSNVGQIAALGQAGSQLTVAHSLGNQGKIIGNGQLDINASTVDNSKGT
LQAAGALNLTKQASLSNDGGHLAAQSLNIKTDTLSNQGGDIRQTGTGVAQ
LQVGQNFNNQHGQVLSNGALTVSANRLDNSQGTLASQGGLQTQLRQDLNN
QGGALLSAQALNLSLPGAINNQQGQIQGNSLQVNGASLDNRGGTVKAIGN
GDHQLHLAGKLDNSAGGAVLSNGNLDLKADQLDNRQGSLQASGLLNARVG
QDLSNQGGQLLAGQLQLDANNLWNQGGKLGQAGTGQTLLTLRGQLDNSAQ
GKITSNGQLTLSSGDINNNQGVLSSQGDLVLHGGNLINRQGTLGSQAALT
VSAGQIDNDGGLVQAGRVLQLDAANLSNGGGRVLALGDGDSRLTVQGQLT
SGGAIAGNGNLQLSAQRFDNSGSVYSQRSLGVNTAALGSVGTLLAGQDLN
LGLQGDFINNGGLQLQAGRNLSISASGNLVNNGQLQSGGSLSLSGLNWTN
NGSVSIGGTFSTHLSQNLYNYGTLGADVLDLNAANVTNAGSITARDISIR
SGNLDNSGGRALLASAGNMALNIGGTLNNHDGAWIYSLGDMRIGQSGAQV
GQVLNHIATLQSDGNMYIEAGRLQNSTSAPTFHIEQKTENDRYDPIIVQD
RGPRGQIEMTTHSVGAYVSYDEVSIDVLDSKNNPARILASGNIIVNAGEI
SNEYSSINAGGSLISVSSVPFKNVGKELNKTTRHVETTVCDGGDFSIRPG
ECSPSEWIGDVAKIKIGSVDAIAQGNNRLYIQAPAIYNTNKGSVNVPSSQ
GSQLSNGSQIGSASGSSVQGAGGGAAADGQTLRAASGERPSGGSVARDVN
AGAGAGQALNGQVSQAAGVKLEGNAASGETGRQLQGKVGAAQGGALQGEG
PAAQAGQTLNGSGQQQIAGQRLSGVVNRVDGAAVGGKSLPSQSSQHTGPL
AGQEVEGSAGQSLAAARLDEQNGAHLAGEVGSLSGHALSGAVSAMTGGAM
GGKALGQAAGQALQGSVGANDAAKLADGVVSALSAAQLGGQAEGPVSAAS
LGDSGIKAAAGMSLSKVLSAVPAMQQMVLEIAGVKAGNPVAHGYQAPDNG
LFHSKPAPSQPYLVETNPQFTQYAKFVSSDYLLKQLSYDPNTVSKRLGDG
FYEQHLVSKAITDMTGRIFLPGYGSAMEQYQQLMNHGAQYARKFQLTPGV
ALSAEQMSQLTSDMVWLVKQTVNDQDVLVPVVYLANADKKSLLGQGAVLA
GSNMTLLADGNLVNSGVLQADATLYAKAGDIHIEGGAVKSAGDLSLNAAN
NIIVADDIAFSKDGVKIEAGNLQMIAGNDLKFRAADVKVSGNGWLQAGHD
IEIGSRQDSYAALSDDKGGAYSWTKNTGSGFNFGGTLGAMAGNDISLIGS
SVKADGGVQAKAGYDINILSSLDTSQGNGSEGWGWRSSSYNYDRKQHNAS
VLNGGGNVALQAGNDLTVLGSSVQSGGLLTAQAAGNITVQSEVDSNRFQL
NGRGSSHDWQNDRLNVAGLSAKGDMLLRAEGDAVLNGANLASGGKLALSA
VNDIKLGAVATERRDDNSWGEEVRNSYDLNQHGTAIHGETGLLLKAGRDI
NTQAASMTSNGQGLLMAGRDVTLGSAVERHSDYSKTVHHSSGWFSSSTTT
DIVAHDSTHEAGSTVSADTVILKGQRDINIHASQVAGSGDVTLDAGRNLN
ITSGTDTSRLFQYHKEETSGLFSGGGLGFTIGSKELTQQLDGAGTTQSQN
RSLVGSIGGNLSIKTGDTFTLQGSDVTAGGNLYLDTKKQNLDVAVDTWHS
VQKTESKSSGLTVQLTSPLISGVQAMASAADTAAKSKDDRVKALSTTAAA
LAGYNSYTAYQQAMKGTDPGKQGYGVKLSISVGGSHSESTTVSDSHTESG
SLLKSGGTLVDLAHGAGQDSTISGKGAQFVAGKDLTLQAEGDIKLLAAKS
TSSEHTTSSSSSGGVGVAFGMEQGKGAFAGFNVNASMSRGHVDGNGSQYQ
LSELNAGGKLNLVSGGNVTLQGIVKGQQVVGDIAGNLKIDSLQDTSTYHS
QSQTLSAEGTYGAGFSGSISYSQQKMDADYASVQRQSGIQAGDGGFQVKV
GDTTTLNGAALASSDKAVADGKNSLQTGALVLKDIDNHTDYSASSTSVSV
GTGGPGGGLPMQASGHDSSTTRAGISGGSLIITNNALQEVQTGQTASQAA
AGANRNVSSDKDGSGKLANNFDANQVQGLFDAASALNQQVSTFISNKIEA
AKEAKEALKRAEDSGLSKDSDEYHKLQQAAIDTEADAAKWAPGSKNGQVT
TAILAGITGNLANGLTGMAQNAGLAYLQGMGAQEVKAYLQDLSNHGMPEG
QTEALRTVLQAAVGCAGAAASGQNCGEAAAGGASAVALNNALNVLQHLKP
EDMNAEQKVDRENLVNTLVTGVALGTGGASTAATTVNAAKTEVENNSLLL
GLGEGFQALEAGSALNARLPGKSTTKIDAELDGKPSSAEKIDKWLKDTWD
GAVEAKNKPGEFADWVLEGFGITKPIDPNSYENGDHKYVPRPDVSDITGV
DGLKRDRPKTPVQGGGGLRPRWKDEMGNIYEWDSYHGELEKYNKNGKHLG
AFDYRTGQQIKPPEPGRKVEK
>CV1470 conserved hypothetical protein
MSGNFVDKNVGNGKTITLNSTPTLAGANAGNYLLAPYVVNAFSANITPLA
ITVSATGQNKTYDGTVHDTVTLSSSGVLAGDTVNFSDTSATFANKNVGNA
KTVSVSGISASGADAGNYTINSTTTTSANITPLAITVSATGQNKTYDATV
NDAVTLSSSGVLAGDAVNFSDTSATFANKNVGNAKTVSVSGISASGADAG
NYTLNNSTATTSANITPLAITVNATGQNKTYDATVNASVTLSSSGVLAGD
TVNFADTSAAFNNKNVGNAKPVSVAGISASGADAGNYTLNNNTATTSANI
TPLAITVNAAGQNKTYDGTVNDTVTLSSSGVLAGDTVNFSDTSATFANKN
VGNAKTVSVSGISASGADAGNYTINSTATTSANIAPLAITVSATGQNKTY
DATVNGAVTLSSSGVLAGDAVSFSDTSATFNNKNIGTAKPVSVTGISASG
ADAGNYTLNNSTATTSANITPLALSVNGAGAFDKLYDGTNAATLYGSIGT
LGSDAVTLSGNGTFASAHVAHDGSGNVIAQSVAANYAISGADAGNYTLTQ
PTGLAAAIRPVTVTANISAANKTYDGTTSATLTSQAPSTAKPWPSTPPPP
TSTPRTPAPARP
>CV3475 hypothetical protein
MLSIMIASSLAACGGGGSGGASTSSQGGGAASQYRVAGQVQKGPFIFGSQ
IWISELNDKLSPTGKVYMTQTKDDLGNFGIPGAIDAKLVELTGSGYYMNE
LTGTLSTAPVTLNAVADLSTSKSLTINLLTTLQAPRLKALMTSGSDYQAA
YTQSRNEVLAVFGIDAGKVDNLGSLFDMRINGTADQDSILLATSSILSQA
AKNQISLPDTETAELSHLISTIASDLTNNGKLSSQSLQDQIKLAATQIDL
DAVRRNVETYYTGRGIKIVAPKFEEWVDKDNSGIIPRRMIEPSAQNFIPT
ENAAPDNLYTSNSIKIDGLKQDESIFVQLIDNATLIKNNQIASSATSAKN
GDTLQVKASAPSFGESKETRVKLGNKNISWLLKSKNTELKFDNTYYDQST
PTPIISTKNDVSYIAFSFTPDVDFVARYAGIDGSSKSSLNMSIYDETTAN
PNNSYAIPGNSLITSNLKTSSFGQKPIPSVNGKLKSNFYPNGIQFSLGSD
GISLKKGNRYWLVVSSIDKSAIEIKGNPGNYDRQITSITYSKNGKYWVGC
QDGTDWNPNYSPYCAGGGLFLFNKPPAIWIAN
>CV0782 hypothetical protein
MSRTRQAGGALPLVMSLLAVLGLLVLSSSRQLAGEARLASNSQDRQRAET
QARQALLGAEQWVWRMDRRLGLDAVDPARLYGEGRLFPPSCDGIEGKGLC
EPMVPPHRRQVGGQSLLHPCGNSREYALEPGPSQTACPQRVRGGALNWAN
PRYVVELIDPRFGESAGDRLYRITVRAWGRHPQSEVTLQSWYRVGEGVAE
GRRLDWREVGE
>CV0311 probable RTX (repeat in structural toxin)
MATSTQGQVLSLQGSVKAIGVDGKARLLKVGDILQPGEQLQLENGAAVSL
SRADGEVVRLEGDRQVMLTDEVLHGQHADATEASIAPLAPEAQQILAALD
NPSANPGNPFDNLDPAAAGLNDAGGENSGHSFIRIGRIAETLTGLQLSAA
PASEALVPENRAADIQTQNSPPFFTAANGAPLGSDMNVATDEDTPVSGTL
TASDPNGDPLTFVKGSDPQHGTVTVNPNGSWTYTPAQDYNGSDKFTVTVS
DGRGGTATVTVNIGVNPVNDPAVITGNDQGAVTEDLNVSAANTLDYNGKL
NVADPDQGEAVFNTARVDNKTNNLGSITIDAAGNWHYSVDNAKVQYLGQG
ETRTEIFTVYSKDGTAHDITVVVNGVNDAADVGHGAGDIGAGAVKEDTAA
QTVASGKLTVVDADQGQAQLQPYQQTTDYGTFQVNADGTWTFTIDNGSAK
VQALGEGDKVPLQFTVVSKDGSASSVVSIQVLGTNDAAVISGNDLGSVTE
DLNVSPANTLDYSGKLNISDVDQGQAVFNTARIDNKTNNLGSITIDANGN
WHYSVDNSKVQYLGQGDTRTEVFTVYAKDGTAHDITVVVNGVNDAAVISG
NDQGSVTEDLNVSAAKTLDYVGKLNVSDADQGQAVFDTSRIVNKTANLGS
ITIDAAGNWHYSVDNAKVQYLGQGDTRTEVFTVYSKDGTAHDITVVVNGV
NDAAVIGGTDHGVVVEDDITQVGGTLLVKDVDQNQSAFQPMADVQVDYGT
FHFDNATGQWTFTLDNAKAQALTSADRFDRTFTVLSLDGTPHTVTVTIIG
KDDPADISGNDQGSVTEDLNVSPANTLDYAGKLNVADPDQGQSSFDTSRV
DNKTNNLGSITIDANGNWHYSVDNAKVQYLGQGDTRTEVFTVYAKDGTAH
DITVVVNGVNDAAVISGNDQGSVTEDLNVSAAKTLDYVGKLNVSDADQGQ
AVFDTSRIVNKTANLGSITIDAAGNWHYSVDNAKVQYLGQGDTRTEVFTV
YSKDGTAHDITVVVNGVNDAAVIGGTDHGIVVEDTILQVGGTLLVKDVDQ
NQSAFQPMADVQVDYGTFHFDSATGQWTFTLDNAKAQELTSADRLDRNFT
VHSVDGTAHTVTVTIQGQDDSAIISGNDQGVVTEDLNVSTANTLDYAGKL
DIVDPDKGQAVFDTARVDNKTANLGSITIDADGNWHYSVDNAKVQYLGQG
DTRTEVFTVYAKDGTAHDITVVVNGVNDAATFSGNDAGAVTEDLNVSAAN
TLDYSGKLNVADADQGQAVFDTARVDNKTTNLGSITIDADGNWHYSVDNA
KVQYLGQGDTRTEVFTVYAKDGTAHDITVVVNGVNDAADVGHGAGDIGAG
AVKEDTAAQTVASGKLTVVDADQGQAQLQPYQQTTDYGTFQVNADGTWTF
TIDNGSAKVQALGEGDKVPLQFTVWSKDGSASSVVSIQVLGTNDAATFSG
NDAGAVTEDLNVSAANTLDYSGKLNVADADQGQAVFDTARIDNKTANLGS
ISIDADGNWHYSVDNAKVQYLGQGDTRTEVFTVYAKDGTAHDITVVVNGV
NDAATFSGNDAGAVTEDLNVSAANTLDYSGKLNVADADQGQASFDTARVD
NKTANLGSITIDAAGNWHYSVDNAKVQYLGQGETRTEVFTVYSKDGTAHD
ITVVVNGVNDAATFSGNDAGAVTEDLNVSAANTLDYSGKLNVADADQGQA
SFDTARVDNKTTNLGSITIDAAGNWHYSVDNAKVQYLGQGDTRTEIFTVY
AKDGTAHDITVVVNGVNDAATFSGNDAGAVTEDLNVSAANTLDYSGKLNV
ADADQGQASFDTARVDNKTTNLGSITIDAAGNWHYSVDNAKVQYLGQGDT
RTEIFTVYAKDGTAHDITVVVNGVNDAATFSGNDAGAVTEDLNVSAANTL
DYSGKLNVADADQGQAAFDTARVDNKTANLGSISIDAAGNWHYSVDNAKV
QYLGQGDTRTEVFTVYAKDGTAHDITVVVNGVNDAATFSGNDAGAVTEDL
NVSAANTLDYSGKLNVADADQGQAAFDTARVDNKTANLGSISIDADGNWH
YSVDNAKVQYLGQGDTRTEIFTVYAKDGTAHDITVVVNGVNDAATFSGND
AGAVTEDLNVSAANTLDYSGKLNVADADQGQASFDTARIDNKTANLGSIS
IDADGNWHYSVDNAKVQYLGQGDTRTEVFTVYAKDGTAHDITVVVNGVND
AADVGHGAGDIGAGAVKEDTAAQTVASGKLTVVDVDQGQAQLQPYQQTTD
YGTFQVNADGTWTFTIDNGSAKVQALGEGDKVPLQFTVWSKDGSASSVVS
IQVLGTNDAATFSGNDTGSVTEDKNVSTTNTLDYVGKLNVSDVDQGQAVF
DTSRIDNKTANLGKLTIDANGNWHYSVDDAKVQYLGQDVTRTEVFTVYSK
DGTSHDITVTIKGVNDPAVFGGTDGATLVEGTFPSATGTLLVKDVDTGEA
AFRPQADVQVKYGTFHFDSATGQWTFTLNDTAQELTSQDKINYTFPVQSL
DGTSHNVNITVYGTDNFAVITGNDKGAVTEDVAVSADGMLVHSGKLDIAT
PDKGRAVFDTGRVDSHAGNYGTLTIDKDGHWQYQVDNAKVQYLGQDETRT
EVFTIYAKDGTEHKISVDVHGTNDAPVFVGDQAHGFAKDGGIQVTTAEDT
PVSGQLHAQDVDANDQLSYATSGNPQHGTVTLGKDGSWTYTPNQDYNGSD
SFKVTVTDKAGATDTITIHVGITPVDDPSVLKPDSGNVVEDKTLAVDAAH
GLLANDYDVDSPLSVQSVTVAGQTYQLGKQGVDVALDGKGVLHVNADGSY
SFAPAAHYAGELPQIGYTTNTGSSSTLTLTMTPVADAPAVGVLIGQGSYQ
PGSPYVGGRNFESWEKTAAEYGKNAITLDDGNNSFADLRGKTDTGFAVRG
MGGNDAIYLDTSKADNVLIGDDGNLNQLSGKPNEVNDTLYAGKGNDILIG
GKGDDSLYGGDGVDTAVYAGNFKDYTITRPVIGAGGSVFFEVTDKQVTAA
NPYAGEGHDSLYDIERLQFKDGTYYWNGKEWAKEGADLTRYPVDISASLV
DRDGSETLDSIVVRLDAKYAGSQLFDSQHNLIGTIGKDGTLTIAQASHWD
AKALDVKLSGLQLEVPGSVKGALSIAVDAVSRETGNGDTATGHASANAAN
MAPETFDVSASGLEDQPLISVALSGKDGDGSVSGFVIKDLPPNGALYSDA
AGTLAVKAGDTVGGTVFFKPTAHWSGDTGFGYAAKDNQGAVDASPAKAAI
HVEAVADAPQLSLGGYSSLASLNFEDVNLGGREWRQDVAVNKIGGANTIG
VWNTDNGRGLIEVGTERTYTGGNSTNKVLEIENGPGDRTLYTDIQCEAGR
FYQLGFDIAARTGWVSSSQLQVKLIALDAFGQPTGKTTVLYDFNPTGTGW
LRDQQVALPIAEDGKYRLVFEAKDGDSYGAILDNLSFKAMDNVGYEGSFI
KLSSINAALVDRDGSETLNVSLSGLPSGAVLKDAAGHQAAVDGSGKLDIS
NWSLDSLQLKGPAGYHGQLNLTVTATATEQSNHSQASSSQNLSVSIQAVD
HPVTLSGLHALDGGSDAIVQESHLAAGTAPDAAQLTQQGSFVVNAPDGVA
SIRLGGVEVVGADGRLTGNTLSTAYGALKVTSFDAASGKLGYQYTLGHAG
ANAGERFVDSIAIDVRDRDGSSASDKLNVAIVNDAPLAADDRASLAVLSG
DLKISSDGIVGNWVGWDGGHRVNTFHQGGNDDGQNQLRWGDTFGQQSGYS
FRDNDALLNNTLPLNQTFKLGDLTHLNYEISGNSGISNATLGLAFTLGVQ
PQQFLVHLNHQETPNSRDYEASKDIVTIDNASQTFEYNGRQYILQILGFD
DGKGHIGNEIHTAENASSTFGIMARIVEGSDYHQPATGGNVLQNDAAGAD
GGLSVVSCASGAQAGNGGVEAILHGQFGDLLMHADGSYNYTFTGDSKLLG
NGQTDTFTYTVRDADGDLSSARLHIDLSTLDPNQRLLQGDAGDNRLTGTD
ANELIRGGAGNDILTGGLGVDTFKWTLGDQGTAAKPARDVITDFGQHGEK
DVLDLKDLLQGESHSASSLEGYLNFHKEGANTVIDVHHQGQGTPVTQQIV
LQNVDLTQGATLSDAQVLKNLLNHGQLHTD
>CV3687 probable signal peptidase I
MKNWLQNNRGFLVFLLLFGLFRTAVADWNPIPSGSMRPTLLEGDVVLVNR
LAYDLKLPLTNVVLQQTGEPQRGDIVTFYSPKDGKHLIKRLVAVPGDTVE
MRRERLIINGRAADYQALQQVTETVSDHVALPALRLRESGALPAHRVQWL
AGVDARSDFGPLSIPAGQYMMLGDNRDNSADSRYIGLVPRELLIGRAVGV
IASADIAGGWMPRWERFASGFH
>CV3826 probable type IV prepilin-like proteins leader peptide processing enzyme
MLDDMTWLLATHPAWLAGAALVFGLMVGSFLNVVIHRLPRMLEREFLADS
VEYLAEGGAPAALRLAAEQARHELDDGGYNLWRPASHCPACRAPVRPWHN
VPLLSYLLLHGRCGDCGEAISRRYPLVELLCGALYGFLAWKLGWGWPLAG
ALALTAVLLALAFIDFDTKLLPDGLTLPLLWGGLLFNLMTGLVPLSAAVL
GAVYGYMTLWLVSHAYKLVAGRHGMGGGDFKLLAALGAWLGWTMLPLIIL
LSSLVGAVCGIAMMSASRVGRGQEIPFGPYLSAAGWIALVWGPQIMNGYL
TWLSR
>CV2869 probable hemagglutinin-related protein
MVDLAHGAGQDSTISGKGAQFVAGKDLTLQAEGDIKLLAAKSTSSEHTTS
SSSSGGVGVAFGMEQGKGAFAGFNVNASMSRGHVDGNGSQYQLSELNAGG
KLNLVSGGNVTLQGIVKGQQVVGDIAGNLKIDSLQDTSTYHSLNQSISAQ
GSMSGGSATLSQQKMDADYASVQRQSGIQAGDGGFQLKVKGATTLNGAEI
ASTDKAAQDGKNSLQTGALVLKDIDNHADFTASSVSVTAGSGGVSGMAMA
ASDHDNSTTRAGISAGSLTITDNALQQAQTGQTAAQAASTANRDVSSDRD
GSGKLANNFNASEVQGLFDAANALNQQVGTFMANKAAEAKAAKAAADKAQ
LDPNKSETEKAQLQAAADDAAKWAPGGSYSQILTAVTAGIGGNVANGLAG
MVQNTGIAYLQGLGAQEVKALADDLERAQSNDPDHADKKPEGEVVRAVLH
AALACAGAEASGQSCGAGAAGGAASVALNNALDKLQHTDADKMTAEEKLQ
RENLVNGLLTGLSTATGGASTAATTVTAAKTEMEHNLFGESVTDQFLYAH
QPKSIRELVARANKDASNKGLALAVVTLGGAYTPAMLAAARACMSNPLCM
NEAAITIAEMAASDALPAGLMGGTAVKSAERYLASRKLGSKQAEQAALAD
FKQAVVAPTTAEVGSTGKVAQKSDAALGSCMTPGSCFVAGTQVLTDKGLK
AIETFVGGEWVWSRSDQTGEYGFQPVVAHKATQDQAIYRVVVEDEIGRQE
TFRTTAEHPFWVKDQGWLKASLLQAGVILVDHAGQPLTVVNQAEEGELDT
VFNIQVAEFQTYHVGELGVWVHNANCCPDLKNIAQEMPAILRPSVLRSAL
DNAKPTSGHPNQLMTILDDGTKIIFRKDFGEQSHIIGGPFQGAGKIDHYN
IEIQSARGKTWENVHVVPDGNGGFTWWGKDKVVKP
>CV1628 conserved hypothetical protein
MYSRSNPPSARPRPAAGDGLSSPAPWRRLALLALVLAQAGCAVGPDFKPP
ALPDAAKRGYAETPLAATTASDERAGPAGAGQRLVNGGDLPAQWWTLFRS
PELDQLIRAALAHNPSLEAAQAALAQARENYNAASGSLLFPNVNAQLGGG
RQRAILSGTAPSEFNVYSATVNVSYTLDLFGGSRRQLEGLMAAADYQRFQ
TEAAYQTLIANVVTAAVQEASLRGQLQSTRELLKAQEAQLAIVDKQVALG
AQARAAALSQGTLVAQTRAQLQPLEKALSQTRNLLATLAGRFPGEGGLPE
FRLESLRLPDELPVSLPSDLARQRPDIRASEALLHQASANVGVATANQYP
QITLSGSYGTQHTVLPNTDLGNTLWSVSGGLLQPLFNGGALSAKRRAAEA
AYRQAEAQYRTTVLKAFQDVADSLRAVDADARALQAQADAEAKARESLEV
HTRQYKLGGISYLSLLDAQRSYQQARIGLIQAQAARYSDSAALFAALGGG
WWQQPAAAN
>CV0480 conserved hypothetical protein
MKTWRAQSGFSLVELMVAITIGLLLLTALVGIMVGGRKDYSTNTGQGMLQ
NAGATLSSVISQTARSAGFFGCSGATTSNALVAATGLLGNFNTPVVGYDA
VLASSTLTLTALNGSNDSTLTDWSPTLDGSLQGLVAKGSDVLVFSGQTNG
SVPVWVNAYASAGATALQTLSASNVAANNLLSVSNCGHASILQVSSVGSA
SGGSVINLRQALDTDFPVGSVAAPLSQTAYFVSQATGAQSALYQAVYDGT
ASSWQLTPVVPGVDALQVWYGVGGSPGVTTQYLPASQVSNWAQVNSLRIA
ALLEGPLGSAPATGKTGCANRTSWSVLGSTVVVPCDTRLRHVYTMTVSLR
NAGL
>CV0479 probable type-4 fimbrial biogenesis protein
MRRGQGRCAAGFTMLEVLIALLVLAMGVLAAIAVILNAERASGSAYLRQM
ANQYAYDMVDRMRANSAQVSAGNYDVASGTSLSTLQSDCATSACSAATMA
TYDKYQWLSDLQNNLPSGTGSVYQPANGGSTERVVQVWWTDGNAVSGGSL
QSVTVRTIM
>CV0768 probable outer membrane multidrug resistance lipoprotein
METDKVNKKSWPQTAGVLLISAVLSGCASFGPDAAPDQMVGADQLKLAVA
GQQNVRADWWRQLNDPELDRLVEATLKDAPSLKLAAARLRQARAAVGIVE
SKDGPQLDAMANAVQIHADPLKALPHNDKDYINAYTAALVGSWEFDFWGK
NHAAVSAALGQQQAVAYEGQQTRLLLTQAVVAQYTQLQRSLAQSRLLSQR
LAIAQSRQKLTQARVNAGLLPGDNQRGNEVSIERLQQQQSALDNDIARSR
HALAALTGQGPQQQDSLNPGKLDAAPQPALDKLDANLLGRRPDIAAQRAR
VESMTASVKEARAEFYPNVKLTVFAGQSSLKMDQLWKSESSLWGFMPAIS
LPIFHSGQLQSNLSKQQAGYDMAVQQYNQTVLDALRDAADAVSGWQNSQR
QLQQSERALQSSRKANDSMAARLRAGLVNKLSLLDSQDALLSQQSANIDA
QAANRLAWASLNTALGGGFDNQAASR
>CV3813 probable type II secretion system protein
MMQAKFSTLLPFPFARANGVILLDGEAGRVLLLREDAKPAAWGEALRVHG
GQLSGVETLTAAQFEKRLSEHYASRDGAAAEMVDDIGQDLDLNQMVESLP
TVEDLLESEGDAPIIRMINALLTQALRDGASDIHIEAFEDRSVVRFRLDG
TLRDVVSPHRALHAAMVSRIKIMANLDIAEKRIPQDGRISLRLGGRPVDV
RVSTLPTSHGERVVLRLLDKENAKLDLATLGMAADTLASVDKLIRQPHGI
LLVTGPTGSGKTTTLYAALSRLDASHTNIMTVEDPVEYHLDGVGQTQVNA
RIDMTFAKALRAILRQDPDVVMIGEIRDLETAQIAVQASLTGHLVLATLH
TNDAASAVTRLTDMGVEPFLLASSLLGVMAQRLVRRVCPQCKAPHPVPLE
DAPEVVHYRPVGCPACGQSGYKGRYGIYELMLVDDTMQRLIHDRASEHRL
RDHADRHGMRSLRDDGMRWVKAGETSLEEILRVTRS
>CV0685 conserved hypothetical protein
MTAMLQKKVLFLALVGACGLAHAAGADTSNDPSSSTRSEISNNLSNTYGN
TNVNQTGTAYLEGISVYEVFDPKADAMATARVDDVQKNLGNKLNVTDPAN
AAMSGSVTGIQGNAGVNNASGFFNQQANNVAITSASGKKSGAAAAVSFEQ
LNDGNTYTFAQPLYGTSNKMDATMSNSVSNIQGNAGINNAAGAGNQQKND
VALSSASSAVLATASAGGTQVNHGIAVTTFLPINGTASITGSVNNVTGNV
GLNNAAGLSNQQVNSLSVAATH
>CV1471 probable adhesin
MELAMNRIYHVIWHYATQQWTVVSEHTCAKKRRSSSSQKISPIALSLLAC
LTNGATAAPIGGQVANGYGSIRQTGSTTTVVQNSQNLSLNWNSFNVSPNE
TVNFIQPNRTSLAVNNILGNSPSQIMGHLNANGQLWLINPNGMIFGRNAQ
INVGSLVASTLSPSSNSSNDTIQFKGSGSGSIINQGHISAAQGGYVALLG
NAVSNQGTIEATAGTVALAGGSEIAVGFADNQLVGIQVNKSTLNNFAENQ
QLIQADGGQVIMTAGAHDSILGSAVNNSGIIEARTLESHNGKITLLAGMA
AGTTSVAGTLDASAPDGGDGGHIDTSGAHVKITPDANISTKASNGSTGSW
TIDPQNYTIAASGGDITGSQVSSLLGSNNITISSTQGAVAGSGDLNVNDA
ISWSNANSLTLTAVRNVSFNSGGTVTNTGGGTLSARADANASGTGTVVMN
GGSINVSGAGGAVNFYYNPAVFGTPSTFSNVTVSGGSKFTPYMLINTASK
LQSMSTNASANYALATNIDASSISNFTPVAFSGNFDGLNYAINNLTVNAS
GNNAGLFSTTSGTATVQNLSLANASVTGHATVGALVGNNAGTIKNVTVSG
TVSGTNTEIGGVAGYNTGSLDRVTSSATVNGTGISGASDYVGGLVGYSTG
GSISNASVSGAVNVAAHNYYIGGLIGYSNSTISNSAATGNVNAVFGGYTG
GFIGYAAGGTVSASYATGSVTAGDYGYDDNAGFIGVNYAPITNSYSTGTV
TLAQSWYSGGLVGQNHANIGNSYSSSNITVSSGPAAGGDGSATYTNSVGG
LVGYNVAGNLSNVYATGNVISTGQGANGTYYGSYYIGGLVGYVGSGNITH
SYATGNVTATALIQGAGGLVGEAVAGTYTNDYASGNVTATQAGYSSPPYL
CRRLDRLSGRDAGQYLFRRQRQRLRRHHQLRRFDRRGDHHHRQLVLGHHD
QRAGHRPIHSRGRDEYGQYANPGQLHLGHDSQWQYQPGLGFFHGLENGHR
RLSVPGIPDSQWTDQHAGAHHACGRGSLLSTDAVQFLRQQQGL
>CV1297 conserved hypothetical protein
MRPGKGSQRYRESDRNMKKLICRGLRGWLLALLLAMPLTSHALGCWNGSN
SSGNVTSTFNLPGNLFVSANAPVGTIIWQSSLQNLSLYCSQSIGENVYFW
VNPKRATLAPGLQIGIIFNGQTYTQSSGAIDTGIYVPRGGYVNTVLQYSI
VLLKTAGAPSSGSSSINQYSVFQLDGIGGINAAPGINFNQLINGSVTFTP
GGTCDLSANGQYTINLPTVASGQFPAVGSAMSRNAFTISAVNCSTGVRTA
TFRFSGTADSNNPVLFANTGGTARGVAINLGSSADGANIGANTTNNTRVV
NVQSQQAQLGLFVEYMRTANIVPGSLQTAVTIDMLYQ
>CV2984 probable flagellar protein flgJ
MDLPSEGAGFAEQFAGVRAEVERFIADGGSASAQQLSPEAWRVRQQLGAG
SVDLSAVPPDRQAFVEEMLPHAQAAAARLGVTPDLVLAHAALESGWGRKP
LTRGDGGNSHNLFGIKADARWRGEVAASLTTEFIHGQKQSRVESFRAYPD
YRAAFDDYADLLASNPRYRAALGVGGDARAFAEALARGGYATDPDYAGKL
AGLAGQFRKGMR
>CV1346 probable transmembrane protein
MSFITPAFASGGAAPAGFDLMGFLPMIVIFVLFWFLMVRPQQKRMKETQK
MLSELQKGDEVVTQGGIVGRVSKVSEQYLSLEIADNVEIHVQRGAVSAKL
EKGTLKSL
>CV3111 probable type-4 fimbrial pilin related signal peptide protein
MDKKQGFTLLELLIVMALLAIVLAFAVPAYQSTVSSNAVMSESNNLYGDI
LSARNEALKRGQVVLVCPSSDGANCNTVAPASTNWAGGWIVLQAVNNSCG
DTSGTVLRRQQAFGSGDSAVYSNSAYPSLCFNRMGYAPSSNVGMLTFNTP
ANQASSRRCVALAAVGHPQVLASGQTDSTGQYTCP
>CV3115 probable type-4 fimbrial biogenesis pily1-related protein
MTALLAASLWPQAAGAVTVSDNFTGGSAQLNWLVFGGACMTAGNGSGTIP
ACGSKDPSGNTQIGGYSGTLPDSNGNGALRLTNSAGSQSGAIVYNSLFPS
SSGLQATFTSYTYDGDSGGSARNGADGMSFFLLTAIPSAVGSFGGSLGYS
CSNVNSPYNGIIGGYLGLGMDEYGNFPNGGYYNDNTSSGPGAKPQNISLR
GAGSVAASSLGTQFGRSFSASMVQSVCRNGNYNGTSVMNYPFISIPGTSG
GVYQLPSSQPMANESATRRGQAVPISYKLKITPANLLSLWYSYNNGAYVP
VITNYDINNTAVSGPLPSQITFGFAASTGASRNVHEISCFQAQPFTQSAS
SSGLNSQQTTLIRTGTQQYVASYHADNWWGSLASYALQGNTSTGQVSVAS
TATWDSSCVLTGGSCATTGASNMNAQTSRAILSWSGSQGIPFQWANLTAG
QQSAISPDGNGSARVSYLRGARGNEVTTLGSGLFRDRDSVLGDLINSSPI
WVGPPQNNYQATWSDKLYPSASPAENATGAQTYPAYQSANATRTNVVYNG
GNDGMLHGFRSGANDANGNYVATNNDGQEVLAYLPAAVQANTVQYSNPTY
PHQYFVDATPVADDLFYNSAWHTWLIGGLGAGGQAIYMLDVSNPANFSET
NAASLVVSEINSGTLSCVNKATCGNDLGYTFGTPVIARFHNGQWGAVFGN
GYNSANGHAVIFIMLVNSSGAPSFYELDTGSGSANDPSGAGGKNGIYYTT
VADLDGDNTADYIYAGDLFGNVWRFDVTGSTPSSWSVSQFGKGAASPLFT
TQYTYCSSAQISAGSCTPSLQPITSKLLVTAIPTGNTSPRVLVSFGTGQK
IPFTTNSADVYAGGTQSLYGVWDWDMSGWNTLTGQSAYYSQAAPTGGLTV
RPSNLTAQTVAASYSSTLGSVQGYRALSNNAVCWQGVSSCSSYGWLLNLP
GSNEQVIYNPVSQLGTFTVNTTIPPNSNPSSCTVSSATGFTMSLNPKTGG
ATLRSYYANDSGNFNGISGSVIDGIAVNMAGSPSVVRFLGNYFAIGSSIS
GGPVATPPQINPAAFDLHARLNWIELR
>CV0399 probable exbB-like biopolymer transport
MNVLTVFQQGDAVLISVFMILILMSVLTWYLIIVRGVQTLSLRRANREAE
NALWGAADWRQAEASLQHSQGQFANLARAGLAALKQYQGQAGRALGQACG
VDEFLTRAIRRALSQEMARQESGLTVLASIGSTAPFVGLFGTVWGIYHAL
VNIGHAGQMSIGAVAGPIGEALVATAAGLAAAIPAVLAYNALTRAQRVMS
QELDYFAHDLHAQLLTQSGDGHGVR
>CV3133 probable flagellar protein FliJ
MGMAQSRLAESRSRLDQLDAFREEYRQRLVGGGGQGMSIVQYQDFRRFLA
RLDEAMIQQQQDVDRCAQRFVMERQAWQMEYKKLKAYEKLLQREQEREAR
QEAKRQQKQTDEFATRRFWDRTHGGDA
>CV2729 probable multiple antibiotic resistance protein MarC
MQLLSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRI
AIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPA
ESSQPSAEQARVDSQAELKQRAFYPLTFPLTVGPGSVSVAITIGATLTGS
GKGLVRFVISPIAGLSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRL
SAFILLCLGVQIMWDGFGELASQWLRDNAGLLH
>CV2873 probable hemolysin activator protein
MNFVIKAACMGGLLFPAWAAATVPDAVLQQNDQQLRHQQQQLEQRRQELQ
QRPDVFSPTPATSPQTALPASDAQHCFTLSRVSLEGAPAGWLAWLQPLAD
AGLAGCVDLARINGLTAALTNEMVARGFVTSRVYLPEQNLRGGQLRLAVV
PGRIHAIQLKAGGSDIGLRSAFPAVAGDILNVRDLEQGLEQLGRVPGQQA
TMELTPADAPGESDVVVDRGGGRLLSGLLSLDDSGQNATGRLQTSGSLTL
GGATGLNDALSLSWSQDAEHLAHPLSQSASLSWLLPLGNWTGFFSYSGFA
YHQTVQGVNQSFTSSGHSRNTLLSLSRLLRRNQSGKTELKLSLTRKASRS
FVEDAEVAQQRRDLTIAGLELSHRQYLGEAVLDGSISYQRGIGAWGAQPD
TLAAQGGPTARHQLYQGRLALQLPLHIASQTLRWSSELRGQYSPDLLMSS
EQFAIGGRGSVRGFNTSTLVGQSGYYLRNELSWPLPQLQGLALEPYLGLD
AGQIARPAYDAGPDRSLSGWAAGLRLSLGGHLSAELSHERALHQPQGWDR
PAITHFSITAQW
>CV3560 conserved hypothetical protein
MAAMKRQLIAFSLLGSLTACSALQQLGVPIHSGSGASSRPAPPRAAAKVD
LLLAEANRLADKVKSGELTRTAAADQLNAARLRIAGSNAVDNDNFAVYRQ
LTAERDAGRIDSDAFRARLEAHLREWMRRWPKYAPKPADPAFTNFLLKLY
GLPPLGY
>CV2765 probable transmembrane protein
MGDIRVSSRLGERLAAELPLLGGAFDKSEQLRVSILPDPSQGAAMKEQLS
LVASITHQLDRSTDGRRMLLLSSSQPITQARLSFRVEVVAGNVRAQKTYS
LALDGAAAQGSEQARAAAKPEPKSAPRQAAEHALDGKVYHVNKGDTLSAI
AMRVRGHARGEDVAGRLLRDNPDAFIRGDANRLLAGAELRYPASWAMRDA
VDREEGGRPEAAAKPGSMAKLLAEGHQADQAKSASSRTEAHPEAKPAAAP
AVKPEAKAVAKPAVKAASSPAALAAERRMRDLLMKQDQALKQTEQRAKAL
EEQIRALQQTKSKPEADEAPASPTARKQEADVSAKPAPAEPKPAIAKPEA
PAAKREEHPSPPVGFMPAASAPQAPPQLAQPVERKPEPAAQAKPQAERGV
AAEAMAALSDRDVLIKLGGAAAALGLVALLLMRRRRAAAEGGESAGHADG
GDQSATMQLKPLTSLMSSLKKGEGIDLDSVDVMAEVEVYLAYGRQDQALL
ILREGLDKEPQRQDLRYKLLEVLASQSDKAAFIEEAATAKRMFGKDSTMW
QRVCELGRAAAPDHPLFEREAGAEPPSASLTAAAPEPRPAVSAPPPGPAA
APAPPSVPPADPAPAAPPAAASAVVEEDAEKMELAKLYMEMGDKETAELL
MREAQHGR
>CV0308 probable agglutination protein
MSQATDLRSVVEKTIVSNPEVRFRFHEFRSSAEETGIGRAGYLPTVDVSY
TSARENNKEPLVNYGPQVTSDFNRKGWSADLSQNLFQGFQTMNTVRQLEF
GKRGKYYEFVDASEQLGLEATRTYLDVLRYRQLLDYAKESYGVHKGIYDQ
IEQKVKAGVGRRVDLEQAAGRLALSETNMINESSNLHDVSARYARLIGEE
PPADLAPAPALQDKLPRDKDLLVSAVRSSPAYLAALENVRAAQSDLKVKR
GAFSPTLDLRAHAEKTDNLNSVYGTHDKQSVALVFNINLFRGGADKARLG
VSAERYNSALDLRDKACRDLQQTVRIASNDARKLSEQMGYLRQHALSTEK
ARDAYLKQFDIGQRSLLDVLDSENELYDSKRALVNAEYDNKLAQARVLAA
SGLLLPSLQLKPIEQQQFESDGDDSQRDACSTAYTPPQPFSTAGIPVHPY
VSTTMADAPDAAALKKTSKAVKR
>CV0780 hypothetical protein
MGRPLQAGLTLLEMMAALAIAAVGACLALPMLGQQMERQRLRGHAMALMG
SLEHARAEALRLNRPVYLCAANLKVNRELQGCLPRQAGSSQSWPEGVLVY
ADQGAANAYYDGGERLRLAMFDGDRVAVRAEERQLALTAEGRLQSSRPVR
FVLSGRSQCLALTVAANGRAWLAEVGDACA
>CV3114 probable type-4 fimbrial biogenesis transmembrane protein
MIAALMMLIVITIIGIALMRSSGLLGKLAGNTREKGRAFEAAEATLQYAE
WWLNQGGNAGAAANCSGRQSTLQVCNNALSNPTATTSWGNAGYTYTPPFM
TASASGGGQTYYQSPQLYIQYLGLNAAGSGAIYQLTAIGYGGNAASVAVL
QSTYTLYSGTTNLGK
>CV3706 conserved hypothetical protein
MQTSFLSATILLILITDPLGNIPLFIAALKQVKPERRKRVVYRECLIAFL
VLSVFMLFGRNFLDLMHLTDESMRIAGGVILFLIAIKMIFPGEGSVFGGD
KMSGEPFIVPIAIPLIAGPSAMATVLLLSTREPGRMLEWMGALTICMLVT
TVTFLFSSRLQKLLGEQAITALERLMGLVLTAISVEMLLSGFASYLKQLH
>CV1455 probable multiple antibiotic resistance protein MarC
MEIEIAKIFIALLVLVNPLGAIPIFISLTPNAGQEERRKIAKTTAIAVAI
VLSLFAVVGETLLRFLGISIGSFQVGGGILVMLIAIALMNAKPGPTKTTK
QEREEAGHKTNIAVVPMAIPLMTGPGTISTVIIYASTAHSWIQVVYLLIS
GLLVAVTCYGALVLASPLSRLLGQTGINIVNRVMGMLLAAVSVEIIVDGV
YRLFPQLTR
>CV1878 probable ATP-binding component of a transport system
MRTQAVSRPFPSRPAGIMFFALCGAGAGLACAGAVGAPLRTQQAMQTTIA
GDHAGDYAEVLDGALTIAPGAALGADGLGTSLRQSGGYSVVGSGAQLTGG
IEMTGHAATRLGVGAGPQAKSYRLAMADGSAAHLDNIWLRSLPDGATSAN
GGTALDLRDHAAATMGANTRIQATVPLSDGMELVAHASAIVDGSRIEGTM
SGAQAAGAALLSLHRATLIGGAQGLVASQQSLVTVSGGQIASLGTTSNPH
GDVDSVGLFAISGGPADAPLSVDVSGHAVIQAKGARSAGLLAEAIDAPIE
VSVRDSVIQGDHDGIVVNMNPVLSGGAKLATLDVAGTQVVSGDGAAIRLG
RGAKAAIALSRNASVNPASGVALLTGAGSEASVTVENAAVNGRAVNQGGT
SRIALGANGVWRGGMSGVDSLTVNAGGLWALDGSSDVGQLAMNGGTVNLN
GGSQAHVLSARTLSGHGNFLLKTDLAGYAGDQLAVSGLATGSHVLTVADT
GRAVADPKSLQVVRTGGGDAGFSLANGAVDLGVYRYRLQRDGFNWNLVPL
TTGRYSASATSVLNLISASPVVWYGQERTLRSRLGELRFDRDRGGAWVRP
YAGDYRILGVTGAAFQQRQSGIALGADQALPLGGGKAYVGGVFNYSHAEL
DDHAGASGAVDAYSVGLYGVWLAQNGAYLHGLASLNRYQNQGQATMSNGV
RAKGSYRQNGVGASLEAGRRFALPRDWFVQPYAQLAGVRMNGATVALDNG
MLAQADHADSIQGSVGASLGRGMHAAKGGVAEPYVRLAVTHEFVKNNSVR
VNGQPFDANLNGSRVEIGAGVSAEIGKRLSGHLDYAYAKGPRLEKPFMLD
AGIRYQW
>CV2872 probable hemagglutinin
MNKHLYRIIFNQSRGQLMVVQEDACGQGKGNGAEGVAATLAAACKAFSLR
LSVLLIGLGLGSSALAADIIADPNAAAGKQPGVIQSANGLPVVQIAAPTA
AGVSHNQYQQFNVGPGGALLNNSATLVNTQLAGYISGNPNLKNGSARIIL
NEVTQPNPSQLRGYLEVAGQRAQVVIANPWGITCSGCGFINTQQATLTTG
TPQLNAQGELTGYQVAGGRVSIDGAGLNAANVDSFAIISRAVSINANLYA
QKLDLVLGRNQVDTATLAAQPLAASPSDAPAFALDVAQLGGMYANAIKLV
GTEKGVGVNQLGTMAAQAGDLQLTSAGDLVLRGQTHSQQNLILQADGQLR
HDGVTRAEGSIQADIAGQTALHQALSAGGDLTLNTGSLQGDGALAAGALA
DGKLTEHGRLAVTSAGALQASGQLLAGGDVSLKAGQADLSQATVSASHGA
LDIRAAGDVNAQQARLSAAGAARLTIDGQLDNRSGQLAATQVDLQLGALD
NSQGKIVQSGQADSAWRINGSTDNRQGVLASAGHDLKLQSGNLDNRGGEI
SHAGAGALRLSADALDNREQGRIASDGRLDAQAAQLDNRQGRLVGVLSAS
VDARQQLNNEGGVLGSDGAVKLGAGGLDNGAGLIQSGQDLQLTANSLTNA
DKGQILALGKDAASKVDVSGELHNQGKVAGNADLTVNAASIDNSKGTLQA
AAGLNLTKQTSLTNDGGHIASQSLKLNADSLSNQAGEIYAQQQLSSQLKT
LDNAKGSVIGGQGVDLTVTDQLHNDGVVGSDGQVKLTAGALENAAGTIQS
GKDLQLTAASLTNADKGQILALGKDAASKVDVSGELHNQGKLAGNADLTV
NAATIDNAKGTLQAANHLELNKQSSLTNDDGHIAGQSLTLKADSLSNKSG
ELYAQGQLTSQLKTLDNSQGSLIGGQGVDLTVADSLHNDGVVGSDGQVKL
NAGALENAAGTIQSGKDLQLTASSLTNADKGQILALGKDAASTVDVSGEL
HNQGKVAGNADLTVNAASIDNSKGTLQAAAGLNLTKQSSLINDGGHITSQ
SLKLNADSLSNQAGEIYAQQQLTSQLKTLDNAKGSVIGGQGVDLTVTDSL
RNDGVVGSDGQVKLTAGALENAAGTIQSGKDLQLTAASLTNANKGQILAL
GKDAASKVDVSGELHNQGKLAGNADLTVNAASIDNSKGTLQAASHLELSK
QSSLTNDGGHIAGQSLMLNADSLSNQAGEIYAQQQLSSTLKTLNNAQGSL
IGGQGVDLTVFDQLHNDGVLGSDGQVKLSAGTLENAAGTIQSGKDLQLTA
SSLSNADKGQILVLGKDAASKVDVSGELHNQGKLAGNADLTVNAASIDNS
KGTLQAAAGLNLTKQSSLINDGGHITSQSLKLNADSLSNQAGEIYAQQQL
TSQLKTLDNAKGSVIGGQGVDLTVTDSLRNDGVVGSDGQVKLTAGALENA
AGTIQSGKDLQLTAASLTNANKGQILALGKDAASKVDVSGELHNQGKLAG
NADLTVNAASIDNSKGTLQAASHLELSKQSSLTNDGGHIAGQSLMLNADS
LSNQAGEIYAQQQLSSTLKTLNNAQGSLIGGQGVDLTVFDQLHNDGVLGS
DGQVKLSAGTLENAAGTIQSGKDLQLTASSLSNADKGQILVLGKDAASKV
DVSGELHNQGKLAGNADLTVNAASIDNSKGTLQAASHLELSKQTSLINDG
GHIASQSLKLNADSLSNQTGEIYAQQQLSSQLKTLDNAKGSVIGGQGVDL
TVTDQLHNDGVVGSDGQVKLSVGTLENAAGTIQSGKDLQLSASSLTNADK
GQILALGKDAASKVGVSGELRNQGKLAGNADLTVNAASIDNSKGTLQAAS
HLELSKQSSLINDGGHIAGQSLKLNADSLSNQAGEIYAQQQLSSTLKTLN
NAQGSLIGGQGVDLTVADSLHNDGVVGSDGQVKLNAGALENAAGTIQSGK
DLQLTASSLTNADKGQILALGKDAASTVDVSGELHNQGKVAGNADLTVNA
ASIDNSKGTLQAAAGLNLTKQSSLINDGGHITSQSLKLNADSLSNQAGEI
YAQQQLSSQLKTLDNAKGSVIGGQGVDLTVTDQLHNDGVVGSDGQVKLTA
GALENAAGTIQSGKDLQLTAASLTNAEKGQILALGKDAASKVDVSGELHN
QGKLAGNADLTVNAATIDNAKGTLQAANHLELSKQSSLTNDDGHIAGQSL
TLKADSLSNKSGELYAQGQLTSQLKTLDNSQGSLIGGQGVDLTVADSLHN
DGVVGSDGQVKLSAGTLDNAAGTIQSGKDLQLTAASLTNADKGQILALGK
DAASTVDVSGELHNQGKLAGNADLTVNAASIDNSKGTLQAASHLELSKQS
SLINDGGHIAGQSLKLNADSLSN
>CV4082 hypothetical protein
MKRRSAGLTTLFAVLTLLAIASLVLLAASRQLVLIHANAQNQHRYHQALD
YAEEGLRQGSLALAQGRPLPADNPRFALKQQTIPPNRVRLRSTGRYDGHL
VTVQRDFLQTDNGGGSNQALTLVGNLDLSGAINLIGDKPVEMTVDGTVTL
SGTVDGIAALQSTGDIIVTGSQTIGTLYANGNIELSNGRYQTVKALGNLT
LRGDAAISELARVNGKAAFLSSPGVSPAVAQAEVKGDVDIAMGGARFGKL
DTEGRVDIRQVGSLDALRAEGDLNVQGWGAPLAATVAGRASYNAGNPDIR
IAFQPGLKLNLQPVPRLELKRPRLDAYDYRGQAHYVFTHAADGGVRVTVR
KIHGLADGEYRLGRDPDKQLPNYLCRATDANGVCRAPATLICKGHSPQND
CFAGSRPGQWKLDGVTFAPGVLWFDGDLEVGNGTYHNTFIASGGIATSGQ
HVSYAVNYAGAVGVCANADFPNLYPDDDCQGGAFKGRPVGNAVLLAGGYV
NGRFRGGDITLGSSSRVFGNVWAGNQLFSSGSTTIHGYVSALAQAGAQGS
RPHQWSASTTIDLRGLPDSFRPDEPPDGGGQGGGGRLKALPYSWMDT
>CV3000 probable flagellar hook-basal body complex protein
MAKLGQSAPAPIAAQEDAATGHSFSQAMVSAVRDVDQQNRLAAEKMTEVD
SGQSDDLVGAMLMSQEASLSFSMLMQVRNKVVGAVDDLIKMQL
>CV0465 conserved hypothetical protein
MAVAGSAGASPANRQRSRGSNMQSDFQTRPRSGGFRLAPLALALALTGCA
VAPQPLSLADRQAQLAADRQIMFGSQEAVTAPVTLQEAMARALKYNLDYR
VKLMEEAMAQRQLDLSSLDMLPKLALAAGYTARSKDNASSSQNVATGEQS
LVPSISTEKRDRTADLNLSWNVLDFGVSYYAAQQQADRVLILEQRKRKVA
QQLMQQVREAWWQAAGAQQLQGRVDALLKDAQSALEDARQVEKQKLRSPL
DALNYRRQLLDVIRQMTAVRNALSQAKPRLAAIMNVSPGQDFQVATPSGM
PVPTLGMDVEHMEEMALLNRPEVVEAQYSSRIGALETRKAIAKLLPGLEF
SVGQHYDSNKFLVNNSWSDAGLRISWNLLNLFSAGPITRAADAQKQVSDS
QRLALNMAVLTQVHVAYLDFQGKARQYQLEHELSGVDQAIYQQTRNAVES
GASARLQGILADANAVFSSLRLYQSYGDLQNAYGLMGASLGLDPMPATTK
GYDLASLSQALKGAESQWQGTVSGGKP
>CV2766 probable transmembrane protein
MRNQGKFKLGVLLIGLAYSACAWAGLGRIHVRSNLGELLKADIEMTGVQP
TELDAVRVGLAGIETFQALNVDYASSLSSLRFALSPNTRGATIRVSSTQP
INDPYLRFVVEAKAPSGRSVREYTVLLDPATYTAQNIVQDVPSYADSDQA
SRYRQAEPAKLAPAAPRELTVRQGATLRSLAAKVKPKGASLRQTMAALAQ
ANPDAFADGDVNHPKPGSKLQVPSARKMRAMSASQVAGILGEPAPAAQAA
PAGGQSGASAAGKGGDVLKLAPGDGADNSKLNDLQQQINAREKALQDATT
RIAALEQQLKALQSSLQASGAKLEPIAQAAAPAPSSSPAAASAPHPVAAA
SAPKPMPKPVEKPHPKPPAHPAPPPAPSLMSRVLGYLPLIGGGVAGVGLL
ALLGIMIARRRNAAADAAGSAALSRNTVGGHGPSTVGGSNSFMSNFTQAA
GAIDAAEVDPVAEAEVYIAYGRDQQAEEILKDALQKDPSRHEVRMKLMEV
YAARPDVASFERLAKEMHAAFDGKGVMWAKAAALGRAIDPSNALYQMPEG
DAEPSPSAGGGEVIDLDQELFGEEAPAPIEAAPAPAEPAPAQEQEADPLA
ALFDTPPGGAGTAPETEAHSLDFDLDAMLSAETEAAEAKAPEPEANMLDF
DFNLEAAPAEEAKPAESSAGGLESLYEDMLAEEPQAAEAPPAPPEAKADG
VSVMDDPLATKLDLAKVYLDMGDREGAREVLQDLLSEAKGALKDEAQALF
DKIST
>CV1918 probable hemolysin
MKKTKFDLSVTGRVAAALTLAFVLADNGMAAGIVAGGANQPQVSTAANGA
QVVNIVAPTAAGVSHNQYQDFNVNQPGAVFNNSLQGGASQLAGQLAGNAM
LGGNQASVILNEVVSRNPSLLLGKQEVFGKAADYVLANPNGITCNGCGFI
NIPRASLLVGTANLQNGAIASLQAANNGNALSIAGSGASSVSVLDLIAPR
LDIRGNVAATDAIRVRAGFNTVDYASGQVIATAPTPDGVGRLDSYFLGAM
QAGRINIVSTAAGAGVNVGGNLAGGDELTVNAAGALAVQAAQLKGRQLAL
SGASVDISGRVDSETGKDSKHDESWFIWKTGESNSVSSKTDASVKRASLQ
GDSVTVSAAGGAHVGAADIQGQDVKLSGASVSLDGQLAESSAQSSDHAWK
NSWAFNQDKSSTTQQQSTARIKAGHDAEISAAGTDIAIAGASVQAGNNVK
LSAAGGVKLSALTETDISRDTGNRKNDGAALETGNWDNSSSQQRLVQAQV
RAGNALGVTAGGDINAQAASLQAGGDAILSSQGKTALATQTSANSSSTQN
GKTYWGGIGGGGNQNNSSSATVNTGSAVNAGGKLFINGDAGIAINGSQAK
GAQGAYAKTQSGGVVIDSALDLTQTRTDQRTGTAFNITSSASKGSTSKQD
AVAASLKSDAELQLISAGDVAVTGSLVKAAQALNIQAVGDIKVASQAVES
HSQSNDTQLALRGVGAETGDQQYRGGVRIEHTSSSQQLDKTDQAGSLLSG
GSVKLAAGNDLAVSGSKLETSGGDASLSGQNVSLAAAQATQRSDQSSTVT
GGGLYLTGGLDKTGAGLEFGQSSSRAVSDGSVAQVSEVKVGGKLDIVAGN
GMGQVQNQGTQIKAGGAVSVVAGDVSNQAASNQQSAQQSSSHWGADVGVN
VDYSGITRPIVNAGGSVAKGDVAGAAGQAGQLGAANLGVDISATGGSAQS
HSQSSAAVTTSIAGSSVSVTAGGALKDQATQYQATQGQVNIRADSHQMTA
AANTQSQSSQASEGGASVRVYTTTGEDVNVKGSGQGSYSSGQGATSAAVT
GSIQSAGGVNIQVNNDASYQGAAINGGSGQVGIQAGGKLALTQANNTSSS
QQHDVKVDVGLGISTSPIDGGSKLGGSGKLGVDNAQSQSASSAAASGSVQ
AAGGIALSSGNGLTVQGGSLQSGGDIKLQSDGKVSLQAATGSDSKTGSGW
GFNVNAGGSQSDGKDTASKGFNVGGGAQLSSQSESSASQAGAQAKAGGQL
TVSSGAMGKDAISLQGSQLSGQGVKLDAENGGISLQSAQNASQKNDWSAN
ANLGGGNTAKTAKDNGQPKAEGVSNTYQVGGGFGVKVDQQDKLANANATV
SGGQVDIHADGQLALSGANISGGKVTGSVGGNVAVESRQDRNNSTTVDVG
LKADRSNGKNPSVVDQAAAAAGPLSGQVKEKATEAVNKVADKVEEKYNSL
AFANGKDSTNPVSFSKDADGGSVKLPDQPTSGEAKSGVVDGALRKGGETL
KDKLLNPQDKGTQVSGVIDVSVKKDDSVGAVSAIRGDAGVDLSVGGKVQL
NGGRISSGGQVNLGDAKVETSSIQTSSYTGAGGVKLDGTPAAIVQQAVKD
VTSGKAPLIHVERSSQTQTVAGEVQSGK
>CV2603 probable type III secretion system ATP synthase
MRLPDIRLIENTLRERLTLAPAPPGQRSGVELFGRVTEIGPTLLKASLPG
ASLSELCRLEPSGIEAEVVAVTGDHVMLSPFKEPLGVTIGSRVRPSGSPH
QLRLGDFLLGRVVDGLGRPLDGDELPADSELRSLDGPAPNPLTRQLIDTP
LPLGVRAIDGLLTCGMGQRIGIFAAAGGGKSTLLGMICDGSLADVIVLAL
IGERGREVREFLEHTLSEEARSRSIVVVSTSDRPALERLKAAYTATAIAE
HFRDQGKNVLLMMDSLTRFARASREIGLAAGEPAAAGGYPPSFFARLPRL
LERAGPAETGSITGIYTVLVEGDNLNEPVADEVRSILDGHIVLSRKLAET
NHYPAIDIGASVSRIMGQIVSAEHRQQAGKLRRLMAAYKEIELLVRVGEY
QPGQDAEADEALERKDAIRQFLCQSVTEKNDFEETLEQLWQTVD
>CV2558 clpP, ATP-dependent Clp protease proteolytic subunit
MKSMMEPQGLGLVPMVVEQSGRGERAYDIYSRLLKERIVFLVGPVTDESA
NLVVAQMLFLESENPDKDIHFYINSPGGSITAGMSIYDTMNFIKPDVSTL
CIGQAASMGAFLLAAGTHGKRFALENSRVMIHQPLLYGGGLSGQVTDIEI
HARELVKVKAKMNELLAKHSGQTLERVQSDTERDNFMSAEEARAYGMIDK
VLSSRRDVTA
>CV1295 ecpD, chaperone protein ecpD precursor
MKQAVWRGALALAIAGSAWTGAASAGVVVSGTRVVYKAEDREVTVKVNNP
GKEPSLVQVWADKGNEKSVPDTADAPFLIMPPIFRVDPAKGQTLRLTFTG
ADLPKERESVFWLNVLDVPPLPKAASEQRNFMQVAFRSRIKLFYRPVGLP
GTPDEAADKLSWSLLPQAGGKGYMLRASNQAAYHVSLNRAVLLVGKHEYE
TDGGMVPPGGSHDFALKDLKLKPEGALKLNYESINDYGAPVAHSISLAH
>CV2597 escC, type III secretion system EscC protein
MRASKWLGPGLVALTCAQAFAAIPWQSSAPFFLSTRGSKLADVLRDLGAN
YSVPVVVSKQVDEPFIGAIRSMPPEQALDQLARLHKLAWYYDGQAIYVYK
AQEVSSQLITPAYLQVSTLISQLQGSGILDRRYCRVRAVPASNAMEVHGV
PICLNRVEQLAKRIDEQKLNHEQNQEIIQLFPLKYATAADGSYSYRGQQV
AVPGVVSVLKDMAQGRTLPLKENQGQQPPTDRSLPMFSADPRQNAVIVRD
RKINMPLYASLIEQFDRKPALIEVSVMIIDVNSQDLSALGIDWSASASIG
GNGISFNSAGQQGSDNFSTVISNTGGFMVKLNALQQKAKAQILSRPSVVT
LDNTQAVLDRNITFYTKLLAEKVAKLESISTGSLLRVTPRLVDEGGQRNV
MLTLVIQDGRQAGTVSQHEPLPQTLNAEVSTQTLLKAGQSLLLGGFVQDE
HSEGESKIPLLGDIPLIGKLFRSTQKNSRSTVRLFLIKAEPAVQS
>CV2607 escR, type III secretion system EscR protein
MSLLDQPLQLIVLLFALSILPLLVVLGTSFLKLAVVFALLRNALGIQQIP
PNIALYGLALILTLFIMAPIGLEIQDNLIAHPIKIESPAFIQQVESGVFT
PYRVFLERNTAPEQVHFFADIGHQIWPEKYQQRIPDNSLLVLMPAFTVSQ
LIEAFKIGLLLFLPFVAIDLVVSNVLLAMGMMMVSPMTISMPLKLLVFVL
MNGWEKLLGQLVLSFS
>CV2608 escS, type III secretion apparatus protein EscS
MSEAMIAQLATQMMWLVLLLSLPVVVVASFVGVLVSLVQALTQVQDQTVQ
FLVKLLAVSVTLAMTYHWMGDVLLNYAGLAFDQITQMRD
>CV2609 escT, type III secretion system EscT protein
MVYWTQWLPVLGLCMLRPLGVFLLMPLFSTANLGGALIRNSLVLMIALPL
LPVYPQWQLPAAGAWGYVLLAAGEICIGLMIGFCAAIPFWVLDMAGFLID
TMRGSSMASVLNPLLGQQSSLFGLLFTQIFGVLFLISGGFNELLEAIYQS
YVTLPPGAAIHYSPEALSFFYRQWQLMYELCLRFSMPAIVVILLVDMALG
LVNRSAQQLNVFFLSMPIKSAFALLMLIVSLSFAFNGLLDYSAHFTKLTD
ALLEQLR
>CV2610 escU, type III secretion system EscU protein
MSEKTEKPTPKKIRDARNKGQVAKSTEITSGVQLAVLLAYFCFEGPHLLQ
ALQGMLNVAISVVNQDLVFGINQLTGAFLELAMRFLGGIAALVIIMTIAA
VIAQIGPLLATEALKPSLEKLNPVSNLKQMFSMRSLFEFMKSIFKVTILS
LIFFYLLRQYSPSIQFLPLSDVATGMRVSTQLLFWMWASLIGFYIIFGIA
DFAFQRYNTTKQLMMSLEDIKQEFKNSEGNPEIKQKRKEAHREIQSGSLA
DNVSKSTAVVRNPTHIAVCLRYQPGETPLPQVTAVGRDAMALHIVKLAEK
AGIPVVENIEVARALAAKTKIGGYISAELFEPVAQILRLAMNINYDDEDD
D
>CV2602 escV, type III secretion system EscV protein
MNQIKSFLMMAAGRQDIVLAVMLLVAVFMMIIPLPTGLVDFMIALNLMIA
VILLMMSLYIREPLEFSAFPSVLLITTLYRLALTISTTRLILLQADAGEI
VYTFGSFAVGGNLGVGLIVFVIITVVQFIVITKGSERVAEVSARFSLDAM
PGKQMSIDGDMRAGVIDANEARRLRGLVQKESQLYGAMDGAMKFVKGDAI
AGIIIILVNILGGTAIGVMMHGMSASAALSTYAILSIGDGLIGQIPALLI
SITAGTIVTRVPGEQRLNLASDLTDQIGKQPQALLLAASVLLVFALIPGF
PAIYFIILAAMVSAAAWWVKKRKRAARSDSTGSPSSESGADAGGETANMS
PGATPLMMRLSPDLIRSSRLPALLDTFRHGKFEQLGIPLPEIQLQKDASL
AAGTLQILLYQEPVLTVSLPERLLLADIASPKLPQSEQTDKLPFGNLSLQ
WQSPTQKEALSAIGVQLHQDEDRIVHCLSIIIDRYAAEFVGVQETRFLMD
AMESKYAELIKEVQRQLPIGRIADVLQRLVAEGVSIRDLRSVFEALIEWA
PREKDPVMLLEYVRMGLRRHIVTRYRAGQPWISGWMIGDTIEGMVREAIR
QTSAGSYSALDPEHNQAIMSCIREAVGDAEKRNQVLITAIDVRRFLRKVV
EREFFNLHVLSFQEIGEEAELRVVGNIDLIGEY
>CV1972 exbB1, biopolymer transport protein
MTKITRAFLGKVLGAAGLLTALPALAAETVSTSNPYGIDALWSQGDFVAK
GTLIILLIMSASTWYVGIVKLLEQRRLIKQGHELLAHHGVDLQKAASELA
DEGMYSAVAQAGIEAAAEHKGELANRVDLNTWVAMAISDAVDSASHHMQN
GLSVIATVGSTAPFVGLFGTVWGIYHALVKIGTSGQASIDKVAGPVGEAL
IMTAIGLAVAVPAVLGYNWLVRRNKLVLDNVRVVSGRLHASLLNNPSR
>CV1984 exbB2, biopolymer transport protein
MTKITRAFLGKVLGAAGLLTALPALAAETVSTSNPYGIDALWSQGDFVAK
GTLIILLIMSASTWYVGIVKLLEQRRLIKQGHELLAHHGVDLQKAASELA
DEGMYSAVAQAGIEAAAEHKGELANRVDLNTWVAMAISDAVDSASHHMQN
GLSVIATVGSTAPFVGLFGTVWGIYHALVKIGTSGQASIDKVAGPVGEAL
IMTAIGLAVAVPAVLGYNWLVRRNKLVLDNVRVVSGRLHASLLNNPSR
>CV1985 exbD1, biopolymer transport exbD transmembrane protein
MARYTRFGHGKGDEDQVLSAINTTPLVDVMLVLLIIFLITVPVVTQTVKM
TLPKEQNIPTQTKPENVVLGVGPDSRIYWNMSPVKDQQELLARLVKEAKK
DPQPEVHIRGDATARYAPIGRIVLAVQQAGIVKIAFITEPPAPGGGE
>CV0398 exbD2, biopolymer transport exbD transmembrane protein
MAFGSFNQGPAAPMAEPNTTPLVDVMLVLLVVFIITTPLLTNAVKVDLPR
AQAAEHQDKPEQIRLVVDAAGKLFWDDQPVAETDLPARFAAAAAANPNVE
LHLSADKAVRYETVAKALAAAQQNGVGKIGFVTAAQ
>CV1974 exbD3, biopolymer transport exbD transmembrane protein
MAMNVGSSGEDDLMMEINTTPLIDVMLVMLIMLIITIPIQTHAVKLDMPV
NTPSKVQVKPVVVQIDIAPDNGVMWNGERLANREALEAKLSAAGKSEPQP
ELHIKPNKDASYAPVAMVLAESQRLGLTKLGIVGSEQFVQ
>CV1986 exbD4, biopolymer transport exbD transmembrane protein
MAMNVGSSGEDDLMMEINTTPLIDVMLVMLIMLIITIPIQTHAVKLDMPV
NTPSKVQVKPVVVQIDIAPDNGVMWNGERLANREALEAKLSAAGKSEPQP
ELHIKPNKDASYAPVAMVLAESQRLGLTKLGIVGSEQFVQ
>CV1973 exbD5, biopolymer transport exbD transmembrane protein
MARYTRFGHGKGDEDQVLSAINTTPLVDVMLVLLIIFLITVPVVTQTVKM
TLPKEQNIPTQTKPENVVLGVGPDSRIYWNMSPVKDQQELLARLVKEAKK
DPQPEVHIRGDATARYAPIGRIVLAVQQAGIVKIAFITEPPAPGGGE
>CV3347 exdD, biopolymer transport exbD-related transmembrane protein
MDFRRGRGREEPEINFIPLIDVLLVILIFLMVTTTYSHFSELKINLPAAQ
GEQQQNKTVEIKVAVAADGAMAVGDARLAPGDKAGLLASLKTAAAGKTDV
VVVVNADARSTHQSVITVMEAAREAGLSQLTFATQNLK
>CV3833 ffh, signal recognition particle protein
MLDNLTSRLSGVMKTLRGNARLTESNIQDAMREVRMALLEADVALPVVKT
FIAQVKERALGQDVMGSLTPGQALVGVVNEELVKLMGDKNDELNLAAVPP
AIVLMAGLQGAGKTTTVGKLAKRLKETQKKKVLVVSADVYRPAAIEQLKL
LASQVGVEWFPSDEKQKPVDIARAAIDHARRHFFDVLLVDTAGRLAIDEA
MMEEIKALHAAINPVETLFVVDAMQGQDAVNTAKAFNEALPLTGVILTKM
DGDSRGGAALSVRHVTGKPIKFIGVGEKVAAIEPFHPDRIASRILGMGDV
LSLIEEVQKGIDQKEAEAMAKKLKSGKGFDLEDFKAQMQQMKKMGGMANL
LEKMPGQLGEMAKGVQGAEAEKAMRRVEGIINSMTPEERRKPELLKASRK
RRIAAGSGVTVQEVNRLLNQFEQMQKMMKQFSSKGGMMKMMRGMKGMMPG
M
>CV3007 fhiA, fhiA protein
MMIINFMVVTKGAERISEVSARFTLDALPGKQMAIDADLNAGLINQEQAQ
QRRRDIATEADFYGAMDGASKFVRGDAIAGILILIINLFGGVAIGALMHN
LSMGDAFRQYALMTIGDGLVAQIPALLLSSAAAIIVTRINDEADMPQQVG
SQMLASPTVLMSAAGMMLVLAIIPGMPWPTFLGFAALLGYVAWRMHARRP
VAASTLNQAAVKSALQGESEIELEWSTLPYADTLGIALGYKLVALLDAGQ
GAPLTKRVKGVRQSLSEQMGLLLPTVNLRDDLRLKPSQYAIQISGNTVAE
AEVYADRLMAIPSPDVYGEVDGIPGIDPAFGMPVTWIALADKSKALGLGY
QVVDCASVMATHLNKVMRENLAELFRHDDVAALGERLAALAPKLAAALGQ
ALTPVQQLRVFRQLLQDNVSLKDIVPIATALLEASDASKDPIMLAAEVRC
ALKRQIVQAIIGPRDEIRAFNLSADLENLLLSALGQAQQTGKPQLDSFPI
DPNVLQQLQANMPVVRDQMKQLGQAPVLLVMPQIRPLLARYGRLFAPGLH
VLSYNEVPENRQVSLTGTLG
>CV1294 fimA, fimbrial subunit protein
MKQIVTAALIGLGVYSSGAMAADGKITVTGNIVAQTCNIAGTSGQNVTVT
LPTVGASALASSGQTAGATPFAINLSNCPSGLKNAQTRFEVGPTVNPTSG
NLLNSTGAGSATNVEVQLLNNNFNAINLSTNANSQVVPISGGSATMGYYA
QYIATGAAGAGSVNTSVQYSMTYQ
>CV1296 fimD, outer membrane usher protein precursor
MTHMTTRQPARRWDLSPLSLLIFGLFGGQATWADGPAAVAAAQDEVQFNP
VFINQNANGKKVDLSRFNQMGGAFPGNYRADVFANAAWIGRRDVQMKEQD
EGRVLACFNRAMLDDLGVDFSRLPQSAAVPGRDEPSRCVDIAAVVPGAFS
SFNSGDLRLDVSIPQKYLRAKARGYVAPEYWDAGAPFAGFLNYNANSYRY
DNGGAGKSTQYYLGANAGLNMGLWRFRYNGSLTQQDNGKGQRQRSYQSAS
AYTQRDVTAWSSVLTLGDYFTPSDMFSSAPFRGVQLSSDDRMLPESLQGY
APVVRGVAETNAKVSVRQNGNLIYENVVPPGEFSIDDLYNTGFSGDLEVT
VTEADGRVRKFVVPYASVPQLLREGQSRYAVTAGQWRDSTLNKRPNFVQA
TYQRGISNSLTLYGGLIAADRYQSALFGSGVNTPWGALALDVTQSWASDL
PFNASSSTMQGQSYRVTYSKLMEATRTNFTVAAYRFSTAGFLELRDYASL
INQVGVVYRAKNKFQLNADQPLGDGRGHVFLTGSTQDYWNQKGRDLTYQL
GYSNSFKSVSLNLSAGRTQDSTGRIVNQYMLSLSMPLGREPSSPLLSSSV
SGSSDRSGSAQVNLSGTTGELRNLSYNVYANANRDRAGANSSGGGGSVQY
ATSVATLTAGASASGSTSQANAGISGALVFHPGGVTAAQSLGESFAVVEA
PGAEGAAVSNTNGVRVNKSGYAVVSSLMPYRQNEITLDPKGMSQDVELQE
TSVQDAPRAGAIVMLKFNTQQGKPVIVALKRPDGSHLPVGATVSGGNGED
FLTMVGQGGRAFLRGMEGKQLMASWGSEAGQQCRFSYQLPQKQADAVCAP
Q
>CV1000 flgM, negative regulator of flagellin synthesis
MKIDNSGKLSGTYSTQSKPSPRASSSSSSSASAKDDSVKIDSLASKLSAI
GNDPSAQQPSFDAAKVEQIKSAIANGSFSINADKIADGLISSAQELLNR
>CV1025 flhA, flagellar biosynthesis protein flhA
MDSILQILRTMKITQLAGPLLIILILMMMILPLPPVLLDIFFTFNIAVSV
IVLLVGINVRKPLDFSSFPSVLLITTMLRLSLNVASSRVVLLEGHTGPDA
AGKVIESFSHFLVGGNVAIGIVVFIIITIINFVVITKGAGRIAEVSARFT
LDAMPGKQMAIDADLNAGLIGEDEARKRRSTIAEEANFFGAMDGASKYVR
GDAMAGILIILINVIGGLIVGVVQHDLPVGQAAETYTLLSIGDGLVAQIP
ALIISTAAGIVVTRVGTDQDMSEQFLGQLFTKPQVLYITSAVIGMIGLIP
NMPHFAFLLIAGSLLALARGMERRNRLRREKELQAAVQPAAAPEQQAAEV
GWHDVQHVDQLGMEVGYRLIPLVDRTQDGELLRRIRGIRKKIAQDLGFLV
PPVHIRDNLEIKPNAYRILLKGVELGKGEAFIGQFLAINPGMVSKEIAGA
ATTDPAFGLPAVWIDAGKREEAQSLGYTVVDASTVVATHISNLLQTHSAE
LLGREEVQALIDHQAKESPKLIEDLVPKVVPVSILQKVLQQLLSEGIHIR
DFRTIVETLADHVPQNQDIDELTSAVRTALSRVIVQQLFPGEAELPLMTL
EPALENVLMQAVQSKAGGGLEPGLAENLLSSAAQQTEQVEIQGYNPVLLT
APGLRPLLARFLRRALPQLRVISHNEIPDNKSIRIIAVIGGSKG
>CV1026 flhB1, flagellar biosynthetic protein flhB
MAEDSDLERTEPASAKRLSMAREDGNIPRSKELSTFAVTMTGVALLMAMG
GQLGHALGEIMRHLFTFDQATVQNTEPALIRFKESLFQALGALAPFFGGL
ALAALLAPMLVGGWNMTFKALEPNFGKLNPLPGIKRLFSLNAATEGLKAI
LKSLLIGGIATWYIWRERGEIIGLLAMPLEAGILKMTDLMIRTFFIVTSA
LILLVALDVPYQLWSYYKKLRMTKEEVKQEYKEAEGSPEVKGRIRQMQRE
AARKRMMQEVPKANVIVTNPTHFAVALKYDDTMRAPQVVAKGSLILAEKI
IDTGKESRVPIMRSPRFARALYFHAELGQDIPAQLYAAAAQVLAYVFQLR
QYQSVGGVAPVYPDQLDVPDELDPYSKRPQDSAPEESR
>CV3006 flhB2, flagellar biosynthetic protein flhB
MAEARQDDKTEKATPQRLRKAREQGQVPRSKDLAAALGLLLALKMMFWLA
PGWLDDFRQLFALAFASLSGQGALENSLSKLFGGTLLLLIKMLAPLAVIP
LTMLLLSLFPGGWVFVLNQISPKFERMNPLAHLSRLASPKHASEIGKSIA
KALVLGWLLYRVASDALHDFFALHSMPLLPTLAGAADLLLSCLLKLAAVF
LLFALADLPLQVFLFLKQQRMSKQEIKEEHKNTEGRPEVRQRIRQLQQQM
AQRGVRKALPGADVIIVNPSHYAVALKYDENRAEAPFIVAKGVDEMALYI
RQLAEEMKLTVLPLPPLARAVYHTTQVNQQIPAPLYRAVAQVLTYVLQLK
AFQAGSRRSRPTLPDLPVPRELSDPEPAS
>CV3137 fliE, flagellar hook-basal body complex protein
MSVNNIDQLLGELKSAAALASGKQAPAAQQTPQVDFSDVLKSTIEQVNSA
QQTSEEMQKQFQLGDNKEVNLQDVMMSLQKASLSFQTMVQARNKLVSAYQ
EIMNTQV
>CV3136 fliF1, flagellar M-ring protein
MADLAEENATPVWRARLNEAGDRFKALPNNRKILFLTALAAIFAVVVGAV
LLNRTPSYKILFSNLADRDGGQVTAALQQMNVPYQLGEGGVISVPADKVY
DVRLKLAAQGLPKASGVGFELMDNQKFGISQFAEQVNYQRSIEGELARTI
EAISSVQSARVHIATPKQSVFVREQQSPTASVMLQLYPGRMLDGGQVAGI
LHLVSSSVPNLPLKNVTIVDQDGNLLSKQAGPDENSGLDQRQLGFVRQIE
EGYVKRIEDILEPIFGRGNARAQVTANVDFSETEQTSETYRPNSSPNPSA
TRSQQISEKLVNGSANPTGVPGALSNQPPSAASAPITLPPGAAPGTANLS
GGSVSASGTLQRDITTNYEVDKTIQHTKVPTGVVKRLSAAVVVNYRRMPD
KSGEMKPTPLTPQEVQQINNLVKEAMGYNSGRGDTLNVVNAAFADNAQPV
TMQERVIDYVSGNGTSLVKYGLLGIAVLYLLFGVVRPIMRDLVRPPAPAP
GAEGEAAAAGAAGPGGRLLGVAGEEGEPGVAAAMAGGGEDPREAQKRQYS
SNLEAVRELVKSDPRMAAQIIKEWISADE
>CV2999 fliF2, flagellar M-ring protein
MAGRQLLPANAWRYLLPIVLLAIGLSVVATLWLWRDDASYKPVFGAQEKV
SGADMMAALDAEKIPYRVHPQTGQVLVPDGDLARARMQLAAKGVVAQLPA
GLELLDKNDPLGVSQFVQDVRFRRGLEGELVQSIQALDPVRSARVHLSLP
RSTSFVTAGGEKGSASVVVTLKPGQQLSSEQIAAVVKLVAGSVASLDPSQ
VTLVDQAGNLLSAHVDLSDGGIAGNNSEAARRFRDEALQNARDLLTPALG
AGNFKVSVTADVDNDRVEETREKYGEAPKVTNEASREETSTERMALGVPG
SLSNRPVNTDSSSPAADKAGNSKNAVTRQYAYDRNITNIKRARGTLRRLS
VAVALNQAAAPGGKGWQPAELANIDKLLRNGLGINAERGDVLAVSTLRFA
QPTPAEPFWEQPETWFEGARWAAYAVALLLAYLLLARPLLKLARQLAERK
LNDYTPDELDVTPDDPLLDNRPLREAASQRQAALSAAPGDSPVVPLLENY
DLPPAGSPVDVMVEHLKGLAAKEPERVAEVVKQWVQNNGRKQ
>CV2997 fliH, flagellar assembly protein
MKHWRPFRFPPLIDGAPLAPDAAAEVQASAADGFRQGMDAGYREGFDSGE
AAGRDAGYQAGLEQGRAEGAAAARAETLAGLETLGAPLAAAIEQLNKLCR
DYQAAQRDEVVDLVAKVARQVIRCELALKPVQILDLVEETLAALPQGAHS
QGEVEVLLNPEECQRIRELAPERAAQWKLSADPSLAPGECRLRGAEFEAD
AGCQQRLERCVDSLREQLAAEEG
>CV3134 fliI1, flagellum-specific ATP synthase
MSGSLLERQRGWLAACGAAAEAASLWQPCGRLVRVTGMVMEAVGIKLPVG
SACRVMLADAHSVEAEVVGFSGDKVFLMPLTNVHGLLPGTPVLPLPSFNP
PRYGSEPGAAQAASNGAAGRQVPVGASLLGRVLDSLGRPLDGLGPIHPDA
WFPLYSQPMNPLHRTPVHDVLDVGVRAINGLLTVGRGQRLGLFAGSGVGK
SVLLGMMARFTKADVVVVGLIGERGREVKDFIENILGEEGRARSVVVAAP
ADMPPLMRLHGAAYATALAEYFRSQGLDVLLLMDSVTRFAMAQREIALAI
GEPPVTRGYPPSVFARLPQLIERAGNGEEGGGSITGFYTVLSEGDDQQDP
IADSARAILDGHFVLSRDLAEAGHYPAIDIEQSISRVMVDVVPQQQMDLA
RHFKQLYSRYQRNRDLISVGAYVSGSDPVLDDAMRRQLPMVSFLTQPMHE
SHDYASCCEQLAGVMA
>CV2996 fliI2, flagellum-specific ATP synthase
MLRQALSQLSVPDTPVATVSGKLVGVNGLLLESVGCPLQTGQRCLVETAG
GGWLQAQVVGFRREVSFLMPFKKPVGLATGARVLPAPDNGGLMIGDGWLG
RIVNGLGEPLDGKGRLGGDAPLAAHPPQINPLKKKPVDTPLDVGVRAING
FLTMGRGQRVGLFAGSGVGKSVLLGMITRHTEAEVVVVGLIGERGREVRE
FVEHALGAEGLAKAVLVVAPADESPLMRLKATELCHTIAAHYRDRGRNVL
LLVDSLTRYAMAQREVALALGEPPATRGYPPSVFGLLPSLAESAGNGEGG
AGSMSAIYTVLAEGDDQQDPVVDTARAILDGHIVLSRELAERGHYPAIDI
SRSVSRCMSQLIDADHAAVARELRGAWSRYQEVRGLLPLGAYVPGADPAT
DRALRLQPRIEALLCQDAGEAAPYAECLSRLQELASA
>CV3129 fliN, flagellar motor switch protein
MSEEELQGGAAGAEEEVSMDDWAAAMAEQETVETQHAVEAEAVPAQGLFQ
EIGAGAVAGGPPNLDMILDIPVQLTVELGRTKIAIRNLLQLAQGSVVELD
GMAGEPMDVLVNGCLIAQGEVVVVNDKFGIRLTDIITPAERIRRLQK
>CV3003 fliP, flagellar biosynthetic protein fliP
MKRALPLLPLAAAGLLAAAPAWAEPLKLLSANAGGSSVDFTIKTQILILM
TALGLLPVLVLMMTSFTRFVIVLSLLRQALGLQQGLPNRLITGVALILTL
LVMRPVGLQVWNEAMVPFDQDKITMQQALEIAAKPVSRFMLAQTGKTALA
QVARLSGEENVARPEDHAFTVKLAAFVLSELKTAFQIGCMLFIPFLVIDL
VVSSVLMAMGMMMLSPLVISLPLKLLLFVLVDGWSLTVNTLVTSIQAY
>CV3125 fliQ1, flagellar biosynthetic protein FliQ
MSPELVISIVQNALYILIIVSAPVLLTSLLVGLLVSVLQAATQINEMTLT
FIPKLLAMFLVLVLAGPWMLNTLIEYTTRLFQSIPNVIG
>CV3004 fliQ2, flagellar biosynthetic protein FliQ
MLTPDIAVDIVNDSLRVVVTLVVLLVLPSLIVGVVVSLIQAATQINEQTL
SFLPRLLIVLLTIALAGHWITGYLMDFCVAMFQRAASQVG
>CV3124 fliR1, flagellar biosynthetic protein FliR
MLAISDIQINAWVSVFAWPFARIVGLFLAEPVFAYRGVPRRFKAAFALVL
TVILAPLLPPLPAEGIAILVQQLLIGLSMGFVMRIVISAVELTGFIIGAQ
TGLGFAMFYDPVHAAQVPVLSQMLSLFTFFLFLAFDGHHVVLGALAHSFQ
VLPIGMPMPAQGIKALTLWGAHLFEWGVWLAMPIIGALLITNLAIGVMTR
AAPQFNIFSFGFPLTIMIGFCTLYLTLPMMIPVIERMYQAGFDMMLRMLQ
AK
>CV3005 fliR2, flagellar biosynthetic protein FliR
MQGLYAQLLDLVPAVWWPFCRLMAAFAIAPFIGDAVVPMRARVGLALALA
VACIPGMPAHSPIDPFTLHGVAASVEQVVIGLLFGLAFQLTLSVLALLGF
LLSSQMGLSMAIMNDPGNGNSSDVVSSLLYLLAALLFFAMDGHLVLVQVV
YASFRAWPLGGGIPQASLPVLAASVGWVMSAAMILALPVVFATFVVQAGF
GMINRVAPALNLFSLGFPVVTLFGLSTLTLLMQVLPPQYLSLSEQTLRLL
NRLLEIGHG
>CV2993 fliS2, flagellar protein FliS
MDYDAYRSYHAVNLEAQTGAASQIELVLVLFDGLLEEIARARGHLQHQRF
EQKGESISKCINILNGLSSALDFESGGEVVTNLARLYDYCAHRLYQASVE
LDAAALDEAEKLLVTLKGGWVGVRDQNAAA
>CV4203 ftsY, cell division protein FtsY
MFSFFKKKTKPAETPQIETPALLAPEQAPAAPETIAPVPEPQREPVAAPI
AETAPASAEAAVAAIPDEPVPLKKMSWTERLKAGLAKTRDKLGKQLAGLF
GGGKIDEDLYEELETVLLTADMGMDATEHLLQDVRERVSLKGLKDSSELK
GALKDSLQDLIGPLEVPLNVEGKKPFVIMMTGVNGAGKTTSIGKLAKYYQ
SQGKSVLLAAGDTFRAAAREQLIAWGERNNVTVIAQQGGDSAAVCYDAIQ
AAIARGIDIVLADTAGRLPTQLHLMEEIKKVKRVIQKALPDAPHEVVLVL
DANIGQNTVNQVKAFDDALGLTGLILTKLDGTAKGGVIAAIAKQRPIPLR
FVGVGESIDDLRPFDSRDYIDALFE
>CV3810 gspH, general secretory pathway protein H
MAFAARARGFTLIEVMVVMLIIGVLATTVTLSLRPDTHRQLNDEGYRFAR
VLEQAGDLAEMGDTLALRWNGKGYAFSRLDDDGDWQPVTEELLAAHEWPE
GISGEGALLDGQPWRGERPLLLWQDGRAAALALRLDGAGRKLTVLQSPLG
RVTVADGS
>CV3809 gspI, general secretion pathway protein I
MKRQQGFTLFEVLVALAIIAVALGALLRATGLAADNAEGMERRMQANWEA
QNQIAMLQALRQFPEPGQQAGESKEDGVEWRWEREISPTPNPNFRKVVVR
ILAPGAGHYVLAEITGYLRQQAGGGG
>CV3807 gspK, general secretory pathway protein K
MRRRQSGMAVIMALLIVALATTAASLVLWQQGLWWHQLENDKSRAQLRLV
ADAGLGWAMEILRFNNGPAGNGVVALSQLWAQPLPQTEAQGVKVSGALTD
LQGRFNVNSLVLNGQTNVKQLKFYKRLLSSLGLPSKLSEPLLKELRGGKD
EDDKPSADGAVAAPQPNRPLARVEMLRWLPGYTPEVMEKLLPHIAALPPS
VTQINVNTATGEVLKAMVLGLGDGNMMVLMKQRQTNYFKDANDFKARLPG
GGVSLQDVDIGAASSYFQLDSRASYDKARLSMRAMIYSNQNVVKLVWRQE
GNDGRSPQARSGGDKHDDAATLSASGLAR
>CV3812 hofF, general secretion pathway protein F
MAAFKYTAYDAAGKEQSGLLEADSARAARAQLRERGLLPVTVDGVSAKTG
GAGSNVLRRGLPRAELVMITEQLSTLLNAGLTLEKALTAVTEQSENARSR
TVLAALRSDILEGKGFAQALSSAPGVFSPLYRSLVQAGEQSGHLDMVMSR
LAEYLDKRQNTQQKVTLALAYPAVVTLVAILVVAGLMSYVVPQVVSVFAQ
TKQSLPFLTRALVACSDFLRQWGVALLIGIAAAAFLIVRALRAPALKRRF
HARVLKLPVFGRLFRALNTARMASTLSILVGSGVPLLTALETARGLMTML
PMQDAVADAMAKVREGVSLSRALNASRQFPPVLIHLISSGEASGTLSHML
DRAAQQQEQEVERKLATFTTLMEPLLILVMGGMVLLIVLAIMMPIIDMNQ
MVH
>CV3811 hofG, general secretion pathway protein G
MKQLKRAAQRGFTLIEIMVVIVILGVLAALVVPKVMSRPDEARIVAAKQD
IGAISQALKLYRLDNGRYPSTDQGLSALVQKPTAAPEPKNWKPGGYLERL
PKDPWGNAYQYANPGTHGEIDIWSFGADGEPGGEGNDADIGNWDSGK
>CV2242 ibeB, outer membrane drug efflux lipoprotein
MKRAFCLLMGAALAGCASPQPDYQRPAAPVPAHWPAADAESGQADIAWRR
FFVDDGLRETIAQALANNRDLRVAAANVQAARAQYRILDAARLPAVQLQG
KSDRQLTRGGDPSLAADSRGVSAGLGVSAFELDLFGRVRSLSDAQWRRYL
ASEAGAQAARVSLIAETANAYLTLAADRSQLAAARTTLRSAERSLELTRE
RLRLGASSALDVSAMETVRQQARADVARYQGQAERDRLALQLLVGAELDQ
TRVPAALEDRPYTLAALPADAPADALLRRPDVRQAENLLRAAHADVDAAR
AGLWPKLGLSASSGLSGVTLAGLLNAPARALSLALDASLPALDGGAAKAG
VDQAEAQRLAALAAYEKALQNGFREVAGALSQRQALAEEKQARQAALASA
EGSLRLAEARYRQGLDGYLSLLEAQRTAQAARLQWIGAHLAEAENMAALY
RSLGGGLES
>CV2630 invA, invasion protein
MNSLLNGARSRPELLILLLMVMIIAMLIIPLPTYLVDFLIGLNIVLAVLV
FMGSFYIDRILSFSTFPSVLLITTLFRLALSISTSRLILIEADAGEIIAT
FGQFVIGDSLAVGFVVFSIVTVVQFIVITKGSERVAEVAARFSLDGMPGK
QMSIDADLKAGIIDADGARERRSVLERESQLYGSFDGAMKFIKGDAIAGI
IIIFVNFIGGIAVGMTQHGMDLSAALSTYTMLTIGDGLVAQIPALLIAIS
AGFIVTRVNGDSDNMGRNIMSQLLGNPFVLVVTAVLALAVGMLPGFPLIV
FLILAAALGGLFYYKRRAAAGKPAPGMPAQAAKGGSAPGDAARTGGADSS
LGLIGNLDKVAAETVPLILLVPASRRAALEQAQLAERLRSQFFIDYGVRL
PDMLLREAEGMDDNRVAVLINEIRADEFPIRFDLARVVNPSEEILALDVQ
PVLERECVWVRPEDGDRLAKLGYQLRPALDELYHCLAALLARHVNEYFGV
QETKHMLDQLEGKYPDLLKEVLRHATVQRIAEVLQRLLAERISVRNMKLI
MEALALWAPREKDVINLVEHVRGALARYICHKFSAGGELRAVMVSAEVED
MVRKGVRQTSAGAFLNLEPAASDELMDLFALGLEGLGVAYKDMVLLASVD
VRRFIKKLVETRFRELEVVSFGEITDSVSVNVIKTI
>CV2628 invC, surface presentation of antigens, secretory proteins
MKPPRLLRRLANPQRLSGPILEAVLPGVAVGELCEIRRNWQEREVVARAQ
VVGFQHERAVLSLIGNARGLSREAVLQPTGRALSAWVGEEALGAVLDPTG
RVVERFSPAAAGGGEARDIDSDPPPYSRRVGVREPLATGVRAIDGLLTCG
VGQRVGIFASAGCGKTMLMHMLIEQADADVFVIGLIGERGREVTEFAEAL
RGSDKRDRCVLVFATSDFPSVDRCNAALLATTVAEYFRDQGKKVVLFVDS
MTRYARALRDVALAAGEPPARRGYPASVFDSLPRLLERPGATGAGSITAF
YTVLLESDDEPDPMADEIRSILDGHIYLSRKLAGQGHYPAIDVLKSASRV
AGQVTDTGQQQAAAAVRGLLARLEELQVFIDLGEYRPGENADNDRAMSLR
DPLRRWLRQRMDERAAYRDTLESMDGFRA
>CV2632 invG, invasion protein- outer membrane
MNKHLLCALLSGCAVLLAQPAASAPQAAESSGYVAKKDGLRGFFDALSSR
LKKPVIVSKLAARKQISGEFDLANPQAMLEKMAQQLGLIWYHDGQAIYVY
DASETRSSIVSLRNVSLQAFNDFLRKSGLYDKRYPLRGDGRSGTFYVSGP
PVFVDLVVNAASMMDKQSDGLELGRQKIGVVRLGNTFVGDRTYDLRDQKI
VIPGMATVIEKLLDGERKPVAGLAPPAAEKRDDIPAMPDFKEGRGLPYQA
GLSLPEALKRDAAAGDIKVIAYPDTNSLLVKGTAEQVRFIENLARALDVA
KRHVELSLWIIDLQKDDLDQLGVNWSGSVTVGNKLGVTLNQAGSLSTLDG
TRFLAAVMAMTSKKKANVVSRPVVLTQENIPAIFDNNRTFYAKLEGERSV
DLQHVTYGTLISVLPRFAADGQIEMSLSIEDGSQARAPDYSSDNKDAGLP
EVGRTRISTVARVPQGKSLLIGGFTRDASERGEGKVPLLGDLPLVGGLFR
YQSAKQTNTVRVFLIQPREIDDALTPDASDLSADLVRRAGIETDPLQQWV
RNYLDREQQDK
>CV2064 lepB, signal peptidase I
MGANLFWVFSAAVVVGLLLILLGGKKQEGAKDWPQSVQWGYLALVIGGFG
LLSDYMSFTAVMLVFVVITGAVWALDKWMLAKKRAASGAQPGHFVDYSRG
FFPVILVVFVLRSFLVEPFQIPSSSMRPGLVVGDFILVNKFTYGIRVPVL
NNVLVPVNQVKHGDVVVFNYPPNPKVNYIKRVIGLPGDTVEYRNKRLTVN
GKPLTDVEDGTYDYIEQGLAQITAQRFRESQGGKTYHVLNNAEAPVVALS
QVQDFPYRDNCRYDDDGFVCKVPQGNYFMMGDNRDNSSDGRYWGFVDDKL
MVGKAFMIWMNFTQLSRIGTQIQ
>CV3568 lspA, lipoprotein signal peptidase
MDSAMTMPGARGWPKWFALAALVIVLDQISKLYFNSRFQYGEIRPVVEGF
FNFTLVYNPGAAFSFLHDAGGWQKYLFTILAFAVSGWLGWNIVKRRFSGL
MNLAAAFIMGGALGNVIDRLAYGHVIDFIMVHYYNEWYYPAFNLADSFIC
VGAALMVADSMKKPSR
>CV3925 natC, periplasmic type I secretion system
MKNHRLPLIAALLMFGAALPAQAFDLVGAWQAARDYNADFAAARAQREAG
QEKAVQGRSQLLPQVSVTGNYAYNNPLQPSQGIGASGNLVANKPYETHGY
NVGLQQPLFDAGKYTGYQKGKIGTELADTTFDAAEQQLILDIAQAYFDVL
RARDTLAATRASKKTYQNLLEQARTAFEVGTATITDTHEAQAGYDGAVAQ
EISDANNLELAENNLKRLTGLEPSGIQTVRDQLPLLPPKPAGLDAWIDMA
QRNSLKIKSAQQNLELARQTVIEKKGNHLPTVTLNAGYADNISNQSGSYP
HTRGSNVGVTVSLPLFAGGGINSQVREATAQEEAARDQLESSRRQVKEDV
RKAFLGVTNGAALVRAQQQLLVSAKSKVESTRLGKEVGIRTSIDLLQAEQ
AYYTALTTLANAKYSYLTARLALAQAAGQLQPDALAEVNQLIMR
>CV0433 oprM, outer membrane efflux protein
MLKRALIPVAVALAVSACAVGPDYSRPKVELPETQAGARAPAVDAGWWKR
FDDPVLNQLIEEAVKSNLDLQAAAARVDQAAAQAGIARAALLPQLNANAG
YQRGRSSTELATPGAPLVSDARSANLTASWELDLWGKLRRSNEAARASYQ
ASRYDRDAAQLALAAQVAQTYFQMRALDAQLDIAKRTLQSREESLKLQTK
RFHGGLISELDQRQAEVEAASARAAVPQFARSLEQTETALGVLLGHSPKQ
LVDGGLARGKDINSLASPPEVPADLPSSLLERRPDVAASEQQLIAANARI
GVAKAAYFPSISLSGALGSQSLSLDSLFTGPTRAWSFAGNLAAPIFNFGA
TGYNVDAATAGQKQALAQYQKTVQSAFKDALDALAANGAARDILQAQTTQ
STALNRTLKLAGLRYDNGYASYLDVLDAQRNSFQAELNLVNAKLDKLNTT
IGVYKALGGGWEAEKR
>CV3828 pilB, type 4 fimbrial biogenesis protein
MEATAGISGLGRALVQHNMLLQQDADAISKQATTSHLSFVEQLIQSKKMT
SRDIAMFSSRVFGYPLLDLASLDTEQLPKGLVDDEVIASRRLLPLLKRGN
KLYIGTSDPTQTSAYHAITFKTGLTVEVVVVEEDKLSKLIGRYQDNSTSA
LKELESEDFGDLEFADPDAQLDSGPQTEVDDAPVVKFIHKMLLDAIGIGA
SDIHFEPYEKYYRIRYRVDGVLKEVAQPPLLLKEKIASRIKVISRLDISE
KRLPQDGRLKLVISKTRAIDFRVSTLPTLYGEKIVMRILDSSGASLDIDQ
LGFEPEQKAHLLKAIARPYGMVLVTGPTGSGKTVSLYTCLNILNKPDTNI
STAEDPVEINLPGINQVNVNEKAGLTFASALKAFLRQDPDVIMVGEIRDF
ETADIAIKAAQTGHMVFSTLHTNDAPSTLTRMLNMGVAPFNIASSVLLIM
AQRLARRLCSHCKQPVEIPKEALLRAGFTKEDLAGGWHPYGPVGCEECRN
TGYKGRVGIFEAMPISDAMMRLIMKNGTSVDISDLAKEEGMVDLRRAGLL
KVMSGVTSLAEVEAVTND
>CV3827 pilC, fimbrial assembly transmembrane protein
MATTAAKKANPGYIWEWEGKDKSGKMIRGELRAESEAVAKTQLRRQGINV
AKIRRRRSGFGKKITEKDITLFTRQLSTMMRAGVPLLQAFDIAAKGHSNP
AVTRMLLEVRADVETGLSLAEAFRKRPLYFDKLFCNIIAAGEAGGVLDTL
LDKLATYKEKVMAIKSKIKSAMIYPSAIVGTAFIITAVIMIYVIPAFKDL
FSSFGANLPAPTLFVIWLSDQFVHFWWLIFGTLFGAIFAFFYAFKRTPKM
QEQMDRILLRLPVIGDIIRKATIARWARTLSTLFSAGVPLVEALDSVGGA
AGNQVYAEATRRIQADVSTGSSLNYSMQRTDLFPNMVLQMTSIGEESGSL
DQMLDKVADFYEEEVDNAVAALSSLLEPAIMVILGILIGGLVIAMYMPIF
KMGQVVG
>CV3116 pilE1, type IV pilin
MKKKPEGFSLLELVIALAVLALLVSIALPSYRSFMMQSNRTAAKTALQDL
ASREESYFAINNNYASQLATLGYASGTVYVPGSGNNLYALSIASATNSTF
VLNAAPQGSQAQDSCQTYQLDNLGNQSNIANGSSGTPLNVSGCW
>CV4209 pilE2, type IV pilin
MKKQRKQQGFTLIELMIVVAIVGILAAIAIPAYQDYTKRARVSEGLALAD
AAKTAVTEYYATNNAWASGTAPFNTTYGLAASITGNSVSSINVLANGVVQ
IAYNSTVSNGALVDLVPTVSAGSVQWYCTYTGSGTTAIASASQLSANWVP
STCRQ
>CV0483 pilE3, type IV pilin
MRGVTLVELMITLAVVAILGTIAYPMYTGYAQRSRRSDAWQALTTAQAQM
EQCYSQYFAYNNAACTVTTASPNGYYQVQIASSTTASAYTLTATPVSSGL
QAADTSCGSFSVGSTGIRSAQNAQGADTSSTCWPH
>CV0833 pilM, type 4 fimbrial biogenesis protein PilM
MLVDKLRLGRSLLEQLGLGKSHNSPLLGLDISSTAIKLVELSRNGRNIQV
ERYVIEPLPKDAVNDGNLVDIEGIAEALRRGWKRLGSPIRSVAIAIPTPM
AIYKKLLVPASQTEDMDELIESEANQIIPFPLDEVNLDHQVLGPSPSSMD
DLEVLLCAARKEKVEERVAVVEMAGLRAHVVDVESFAMMTAFEQIQQQLP
EEGMNQTFALFDIGATRIHCNIIRNNQQIYYREQMFGGHQLTRDVQRRYN
VSFEEAESGKRSMALPDGYESELMHPFIDSLAQEIQRALQFFYTTVSVSQ
YLRVDYILLAGGCSMLPGLDDAVAGRSQISTMIANPFTTLVQAPGIRLKE
LLMDAPSLLIACGLALRRFD
>CV0832 pilN, type 4 fimbrial biogenesis protein PilN
MIRINLLPHREQKKAAHRLRFQLMLGATVLASLLLLTIGYLTLQHQIAGQ
EARNLFLQKEIGKLDRQIKDIGKLKKQRDDLLARKQLVERLQEGRNSAVH
LFDQLVRQTPDGVYLKSFKQTGNQVTLTGYAQSGARVSSYMRLLGQSETF
DAPVLVEVSSSIVNNQRVSAFTLNAGIRQSPPANKPAGATP
>CV0831 pilO, type 4 fimbrial biogenesis protein PilO
MDELRALDPKDMPNWPLQAQGLMMFLLLLLVVGLGYFFVLGEQLDKLNQS
RQQEATLKQTFVDKKRQAVNLDALEQQLKEIDASFGALLKQLPTKSDMDT
LLTEINQAGIGRGLQFDLFKPGGETRTAEMAEVPITLRLTGTYNDLAAFV
NDVAQLSRIVTIGEISLTPTSGNRLTMDATARTYRALEPGERMSVQAQK
>CV0830 pilP, type 4 fimbrial biogenesis protein PilP
MRTIAICLLPLLLSACGDNSSEDLKQWMANSSLGLRGQIEPLPQVQTYKP
FNYQAYDLTDPFNPQKLQAGKQQNAANAPDLKRPREALENYDLDKLAMVG
TIRRGGAVYALIRTPEGAVYRVQPGNYLGLNFGKITSISDAEVQLAETVE
DLNGEWVQRSSGLHLEEQGQNK
>CV0829 pilQ, type 4 fimbrial biogenesis protein PilQ
MKRLGIALWTGLALCLSGGLAAAAPAITALDAGKVDGNRQTLQITFDGPA
VKPNSFALSNPPRIALDFANTGVKMAKPSLNVDSPLLRSAVAVEASGRSR
LVLSLARNASYRSEVSGNRLLLTLDGSMSTEQAATPQELVPTSRADAQAQ
IAAKGAAGLDFRRGRNGEGRVELALPSANTPVDIRRDGANLVVDIAGASL
PPQLVRRVDVTDFGTPVAKVDAANLGGNIRVTVIPQGDWEYSSYQTDGKL
VVEVRRPALETAGGAAGKPQYKGDKLSLNFQNIEVRTVLQVIAEFTGLNV
VTSDSVTGNITLRLKDVPWDQALDLILQSKGLDQRRNGNIIQIAPRDELL
ARDKQVQEARQQLATLEPLRSETFVLRYRSAEDFKKVLDGDNNSGKKESL
LSERGSVLIDPKTNTLIVNDIGTAIDKIRDVITKTDIPVKQVLIEARIVE
ATDNWERDLGIKLTYDRMDPKGIISGNPLGTNVNNVTNLNNNQPYVIQTT
PAGVNLPIATPYGTLSALYNVGHSVILGLELQAMQAEDKGRIISSPRVMT
ADRQEASIEQGTEIPYQEASSSGATSVSFKKAVLRLNVKPQITPDNHVIM
DITVNKDSANFEKTVNGTPSLSTEKIITQVLVENGGTVVLGGIYQQQLND
VINKVPFLGDIPLLGALFRSSQKIDKRSELLIFITPKVINDLVAESR
>CV0179 pilT, twitching motility protein PilT
MEISELLAFTVKNKASDLHLSAGLPPMIRVNGDIRRINLPPLDHHDVHDM
VYDIMNDYQRKTFEDTYECDFSFELPGIARFRVNSFIQNRGMASVFRVIP
SKVLTLEQLSAPRIFQDIANYPRGLVLVTGPTGSGKSTTLAAMIDYVNEN
AFSHILTVEDPIEFVHESKKSLINQRELGLQTHSFANALKSALREDPDVI
LVGELRDLETIRLALTAAETGHLVFGTLHTSSAAKTIDRIVDVFPAGEKE
MVRSMLSESVRAVIAQTLLKTKDGQGRVAAHEIMIGTPAIRNLIRENKIA
QINSMIQTGQQHGMQTLDQCLADLTRRNIVSPAEARAKASHKDAF
>CV1458 pilU1, twitching motility protein
MLMLPFFKLMAEKKASDLFLTSFSPPMLKLGGELTPVNEKPLTPDMVKQL
AYSLMSEEEAAVFEREREMNLGHPVPGLGSFRVNVFWQRGSVGMVVRYIL
PSIPTVEELQLPPLLEELIKLKRGLILVVGSTGSGKSSTVAAMLQSRNRS
MKGHILTIEDPIEFLFRHDQSIVNQREIGFDTLSYARALKNAMREAPDVL
MIGEIRDPETLSQAIGYAQSGHLCISTLHGNNSYHMLNRVMNFFPAEARG
ALLMDLSASLRAVISQRLVATLDGGRVPALELLINTPHISELIRAGEMDK
IKEAIESSMSDGAQTFEQALFQLYQAGRISLDEALKNADSPTNLYWLINQ
SQEAGKGKDKPGPASAASFDSIKLDL
>CV0180 pilU2, twitching mobility protein transport fimbria
MEKDQASKFIHDLLKHATGKNASDIFIAAEFPPAMKIDGKITPVAPQALT
ALQSKELVRAVMNDRQTEEFEAKKEANFAINPPGVGRFRVSAFVQQGMVG
MVLRKINTEIPTFDQLNLPEVLKDIALIKRGLVIFVGGTGSGKSTSLAAL
VDWRNSNNQDHIITIEDPIEYVHTHKKSIVTQREIGVDTENWEVALKNTL
RQAPDVILMGEIRDRETMAYGLQFAETGHLCLATLHANNANQALDRILNF
FPEERHQQVLMDLSLNMRAIISQRLVPHKSGRGRVAAVEILLNSPLVSDM
VFKGEIAGLKEVMGRSREAGMQTFDQSLFELYEAELITYEDALRNADSIN
DLRLRIKLYSESARNRDPLEGIDHLDIV
>CV3112 pilV, type-4 fimbrial biogenesis PilV transmembrane protein
MSMSAPRQSGFSMLEVLVALIVISLGLLGIAGMQAAAINSTSIARSRSLG
AIAAQSMAAAMHANTAYWGALSASGSWSVSASGVISGTPSLSQTVVCSAS
GTTCTAANIAGYDATQWGSGTISALPGGSGQIACNPASSATPVVCTITVY
WLEKSRSVNAASMTAATASQSYQMVVVP
>CV3721 pilZ, type 4 fimbrial biogenesis protein
MDAANHRPDLNNPNRPGVLSLHIKERSALFAAYMPFLRNGGIFIPTNKEM
QLGEEVFLLLTLMEDPQRIAVQAKVVWITPGGANNSRVQGVGVEFVSGEA
GKQAKDKIEALLGGVLNSSRPTHTM
>CV2420 prgK, cell invasion protein; lipoprotein, may link inner and outer membranes
MMKACLKALLLAAALSGCQQKDLLKGLDQQQANEVIAVLQRHNIEADKAD
RGKAGFSIAVAPADFAAAVDWLRAYDLPSRPRMEVAQMFPADSLVSSPRA
EKARLYSAIEQRLEQSLQTMDGILSARVHVSYDLDSGEAGRASQPMHISA
LAVYDRDVDAAAMINNIKRFLKNSFAEVDYDNISVVLSRREEAQQQPPGP
APKSNAASLSWLIAGIGLALLAGIAAWWRMRRGSRAGEPRNG
>CV2606 pscQ, translocation protein in type III secretion
MSFNHREAGPGLSLIAQLDDQPVRLWMAEAQWLQWVEPMLSLPSWDMAPP
DLRELLAVWTLADAGSGLDDLGLPWPQATRLEPEPIDAGMGWRLRILRDE
RQLDLLVRDAPQSWLDAVAEQAYPIEMDETETAITAGVSLIAGWSMVEMA
SVRKLVVGDALLLRYSFDVAAGKFGLFNRQPIASLMQDGETGIFTVETLM
SDFEDWMDITPTLSPAEEQALGDAMITVTVEVAKMELPLHQLGNLQPGTL
LSSAVSSDGLVTLKAGSRPIARGTLLDIDSRLAVRIEHLC
>CV4281 secA, preprotein translocase secA subunit
MISSLLKKVFGSRNDRLLKQYRQTVARINALEPAMQALSDEALAAKTQEF
RDRLGKGEKLDDLLPEAFAVCREASRRVLGMRHFDVQLIGGMSLHQGKIA
EMRTGEGKTLVGTLPVYLNALSGDGVHVVTVNDYLASRDAGIMAPLYNFL
GLSVGVNLSQMAHDDKQAAYACDITYGTNNEFGFDYLRDNMVFSVDEKVQ
RKLAFAVVDEVDSILIDEARTPLIISGPADDNIDMYQRMNAVPPLLKRQE
TEEGEGDYWVDEKAHSVLLSEAGHEHSEEILTRLGLLKEGDSLYSATNIT
LMHHLMAALRAYSLFHKDQHYVVQDGEVVIVDEFTGRLMAGRRWSDGLHQ
AVEAKEGVEINRENQTLASITFQNYFRLYGKLSGMTGTADTEAYEFQSIY
NLETVVIPTNKPMIRKDSQDKVYRSAKEKYDAILADIKDCHERGQPVLVG
TTSIENSELVANLLSQAKLPHNVLNAKEHAREADIVVQAGRPGMITVATN
MAGRGTDIVLGGNPEPEIKAVRADDSLSDADKNARIEAIRAEWKQRHAAV
LEAGGLHIVGTERHESRRIDNQLRGRSGRQGDPGSSRFYLCLEDPLLRIF
ASDRVAAIMDRLKMPEGEAIEHPWVTRSIENAQRKVEGRNFDIRKQLLEY
DDVANDQRKVIYQQRNEILVEEDVSDVVINMREGVISDLVDLHLPPESLE
EQWDLAGLEKTLASDFLLEVPVAEWIKAEPNLDIEQIRQRIVDMAAAAYQ
AKVDQAGDGVMRQFERSLVLQMLDNHWREHLAAMDHLRQGIHLRGYAQKN
PKQEYKREAFELFADMLERIKRSVVQVLMTVQIRGQEDVDAVEPHALPDF
EMQHAEPGSALGDDEDNPLSPEALASQGLRINRNDACPCGSGKKYKQCHG
RLA
>CV1127 secB, protein-export protein
MSEQQELQPAFSIEKIYVKDISLEVPNAPQVFLEQAQPEIDMQLASAGQQ
LDDGFFEVTLTVTVTAKLPEKTMFLCEVAQAGIFQIRNIPGEDLDPILGV
ACPNILFPYARETVSSVVNRAGFPPVLLAPINFEALYMQQRAQQAEAGNA
>CV1345 secD, protein-export membrane protein secD
MNRYPLWKYLVIVVALIISAIYTLPNFYGETPAVQVSSSRQSIPVDSAVM
ARVEDALKSQNLSPDGVFLDANSLKVRFKDTDTQLKARDAIQHALGDNYI
IALNLLPASPSWLASLHANPMFLGLDLRGGVHFLLEVDMKAATDKAMERY
AGDLRRELKNKQVRYGSIKRNGNTLEVQLRDEDTLKSAQDVVYRMLPSLA
VRSDDASNKLLLTLKPEEITKIQNDAVKQNITTLHNRVNELGTTEPIIQQ
NGPNRIVVQLPGIQDTARAKDIIGRTATLEVHMVEDDQGKVAEALAGNVP
AGYELLDEATSRGQSKILLKSDVELTGDNINDAQPSFDQFGAPAVSINLD
STGAAIFRQLTAENVGKRMAMVLVEKGRKEVVTAPVIRTEIGGGRVEISG
SMNSAEANDTALLLRAGSLAAPMNIIEERTIGPSLGKENIEKGFHATLWG
FAAIAVFMVIYYGLFGVFSSLSLAINVFLLIALLSMLQATLTLPGIAAIA
LALGMAIDANVLINERIREELRNGMPPHSAIHAGYDHAWHTILDSNVTTL
IAGLALMIFGSGPVRGFAIVHCLGILTSMFSAVLVSRGLVHLWYGRRRKL
TSLAIGQVWKPENKG
>CV4199 secE, preprotein translocase transmembrane,secE subunit
MEMQDKIKLILAGLVVVAGVVGFYLIPEGQGLLRALAFVASILLAAGVVW
TSAPGKGLVTYANESMVEARKVVWPTRKEATQVTLMVFVFVTVLALFMWL
VDSSLSWLFYDVILGRGR
>CV1344 secF, protein-export membrane protein SecF
MELFRIKRDIPFMSYGRLTTAISLVTFILAVFFLATRGLNFSVEFTGGTV
LEVQYQQSANLDQVREKVDALKLGESTVQNLGTSRDVMIRLPNKPGTSTA
QLSDKVMGQLKAADPTVQLRKVDFVGPSVGEELVTHGLTAVILVCVGIML
YLAIRFEWRFAVAAIIANMHDVVIILGCFAFFRWEFSLTVLAGILAVLGY
SVNESVVVFDRIRENFRKPGMRGHAVAEVIDNAITSTMSRTIITHFSTEM
MVVSMLVFGGPALHGFAMALTIGIVFGIYSSVLVASPIALWLGVKREHMI
KPVKQKEEAVV
>CV0940 secG, protein-export integral membrane protein
MELLKTLIWIVNLLSAASIIVLVLMQHGKGADMGAAFGSGSSGSLFGASG
SANFLSRTTAVVAVVFFSTSMALVFLSGGGKSDLGVMGNGSKIEQVAPQI
PAGAPNKNASGTASKIPE
>CV4166 secY, preprotein translocase secY subunit
MANTSLVANANKFGDLKRRIWFLIGALIVYRIGAHIPVPGINPAELAKLF
HTSQTGLLDMFNMFSGGALSRFTVFALGIMPYISASIILQLAAEVLPSLK
QLKKEGDAGRRKITQYTRYATVALATFQSFGIAVMLYKQPNLVMTAQWEF
YLTTVVSLVTGTMFLMWLGEQITERGIGNGISLIICAGIAAGVPAAIGKT
LTLTSQGSLPILFAILLFVGVILVTFLVVYAERGQRKVLVNYAKRQVGNR
VMQGQSTHLPLKLNMAGVIPPIFASSIILFPATVLGWFGQGEHMAWLKGV
ADKLHPGQPIYVLLYAAAIIFFCYFYTALVFNPKETADNLKKSGAFIPGI
RPGEQTSRYIEKIILRLTLIGAIYITLVCLLPEFLILKWNVPFYFGGTSL
LIIVVVTMDFMAQVQSYVLSHQYESLLKKANFKGNALTR
>CV1917 shlB, hemolysin activator protein
MRSRETYAVNKRLPIVVAAWLACCQSALADSLPPQAEHDGADARRLLQDS
DRRFDNLIQQQRMRQLKSEGSNLEAERAPQMEGGSCLPVSGLKLAGIRLL
SREEVTALGPPRGTCLDIAELNRFSRALTALYLERGFIAARVRPEGPDAD
GALTLRVVEGKVAAIRGDADAPKAGNLFPGMLGKPLNVHDLDQGLDQANR
LRSNKVTVDVLPGDAAGESALQLHNQPAVRLSGGLSLDNAGRDSTGRMQA
GASLNWDNPADWSDLLNLSVQTTTARQEIRHSRSESLFYSLPYGYWTLSA
FASHADYLIPNTLQSGLVVQLSGTTEQNGLRLDRVLSRGQNHVLTADAQL
VQKRVRNFFQDVRLDSSMNLTVLEAGVSQLLIQPAGLLQLDGSVQRGVRW
LGADAPDPLHPGAANPQFTKLRLGLAWFRGLALPGGPYQLQIALSGQASR
DELPGVERLDIADASAVRGFRNNSLVSETGWYWRNTLSRRFMAGGWSLTP
RVGVDGGRVLQRDARETWQDIAGAAVGLALARGGLTLDLDYSRPLRKPQG
WLSEGHILFARLNWQW
>CV4267 smf, smf protein
MSGAPQAWLTLALTPGIGPVGFLKLIDAFGSAEAAAAARPAQTEKLVGRE
AAEALQAGAAAESAQAALAWAEGDGCHLITLLDADYPAQLAEAASPPPLL
FARGRRELLARTMLAVVGSRAATQQGKRNAEDFASALAAHGYTIVSGLAS
GIDAAAHQGALAHPASTVAVIGTGIDRVYPASNRQLAHRVAEHGLILSEF
PLGMGPLPGHFPRRNRIIAGLARGCLVVEAGIASGSLISARLAMENNRDV
MAIPGSIHNAQARGCHRLIKDGARLVESVDDVLDEIGRLPAAPPPPLRQE
EPETPPLLNSMGWEPVLADALAGTLGLTPGEVYAMLLELELAGRVASLPG
GRFQRLAQL
>CV1815 sohB, serine protease
MSDTQNWERQLLEKLASASLVEQRRSRQWKIFFRLAWLLVIGLIAASVFM
RGEEKSGASLTGGGHTAVIELDGAISSENETGKKMISALDHAFRDKGTKG
VIIDANSPGGSPVLSGMVYDEIRRLKKLHADIPVYVVVSEVCASGCYYIA
AAADKIFVDKASIVGSIGVLSDGFGFTGAMEKLGIDRRLKTAGENKAMGD
PFSPPNPKHDAIRQQLLDDIHHQFIQAVETGRGQRLKKDAQTFSGMVWLG
EKAIPLGLADGYGTVASVARDVVKAQKTVDFTQQDDFSSRVARRIGVEFA
GGVKSLFDAKLF
>CV2625 spaO, surface presentation of antigens; secretory proteins
MRLALRQVDGAALALRRCGEAWAGQDVRIAYPPSHGCWLKVAGADGSWQG
WLQPRAWLRHMAPELASLASAAGMDDRLSELIAACEAPLSWPVADMPLGR
IVAGERREGSQLPQRPMLRMDTPQGEVWLEKAPAPAEAARDRVPGWLPMP
LRFLLGDSMVSPSLLRRAKAGDVLLISRPAQTVSCNGRAIGTYQWTEEGI
IMEWQNEMAAAAETRPLADLDRLPVRLEFVLQQSEVTLDELRELCRSNVL
PLSADAERRVELRANGALLGRGELVQLDGRLGVEVAQWLGGSGDVE
>CV2624 spaP, surface presentation of antigens; secretory proteins
MSNDISLIALLAFSTLLPFLIASGTCFVKFSIVFVMVRNALGLQQVPSNM
TLNGIALMLSMFVMLPVAQQAYGYYQEERVSFTSVEAVNNFVENGLDGYR
GYLQKYSDPELTRFFEKAQSQRSERDGGEAAAPDDKPSIFALLPAYALSE
IKSAFKIGFYLYLPFVVVDLVISSVLLALGMMMMSPVTISVPIKLVLFVA
LDGWTLLSKGLVLQYLDLAT
>CV2623 spaQ, surface presentation of antigens; secretory proteins
MNDLVFAGNKALYLVLMMSAWPIIVATVIGLLVGLFQTVTQLQEQTLPFG
IKLLGVSVCLFLLSGWYGETLLAFGREVMRLALAKG
>CV2622 spaR, surface presentation of antigens; secretory proteins
MQFSFFFEVHGWVAAAAIGFARVAPVFFILPFLNGNTLTGMVRTSVAMLV
ALGLWPHPPLAMHAMQAWPLLALLMREATVGLLLGCLLAWPFWAFHAMGS
IIDNQRGATLSSSIDPANGVDTSEMANLLNLFAAAVYLQGGGMELMLDVM
RQSYQLLDPLGDGLPPLAPVLSLLNQVIAKSIVLASPVMATLLLSEAVLG
LLSRFAPQMNAFAVSLTVKSAAALLIMLLYFAPVLPDAVAGLALRPGALG
TWLVR
>CV2621 spaS, secretory protein / flagellar biosynthetic protein flhB
MSSNKTEKPTRKKLQDAAKKGQSFKSRDLVVACLTLCGVAYLVSFGSLVE
LMGIFRQALAGGFQLDMRGYAQAVFWQGLKLLLPIFLLCVAASALPVLLQ
TGFVLASEALKLNLEALNPINGFKKLFSLRTVKEAVKALLYLASFVVAVA
LIWRKHKALLFAQLNGSVMDIAAVWRELLLSLVLTCLGCIVLILILDALA
EYFLFMKDMKMDKQEVKREMKEQEGNPEIKSRRREAHFELLSEQVKSDVE
NSRLIIANPTHIAIGIYFRPELVPIPFVSVMETNQRALAVRAYAEKVGVP
VVRDVPLARRILASHRRYSFINLEEVDEVLRLLEWLEQVENAGRPDDEPS
GGP
>CV2588 ssaJ, type III secretion system apparatus lipoprotein
MKALRRLWPLLILMSLMGCKVDLYSGLSEDEANQMLALLMLRNVDAEKKI
IKEGNVTVRVEKEQFTDAVEVLRQHGLPSKRTETMADLFPSGQLVTSPAQ
EQAKIGYLKEQLLEKMLRGMDGVISAQVSIAESVSQNRREAPAPSASVFI
KYSPGINMQSRETDIKRLIHTGVPNLRSENISVVLQAADYRYRPTATTAQ
PAKNTQSWLRKYAIWLVGGLTLLGCAAAIGVLAWRRRTAAS
>CV0623 tatA, Sec-independent protein translocase protein TatA
MGSLSIWHWLIVLLIVVLVFGTKKLPGIGKDLGNAVKGFKEGMNEGAKDG
QPPAKDAGRIIDGEADKK
>CV0624 tatB, Sec-independent protein translocase protein TatB
MLDISFGEFVLIGVVALVVLGPERLPTVARTVGALVARAQRFVANVKADM
QQQANLQGLDSLRQDLQDAAHSFRGQLEAEVQQVRDAIDQNAADARALAE
QAAEPFHEAERTIHGGLAPDAEAEAREAETHPAEPAPAAQADVPPRDENQ
LDLFDDLPPHRPPASQPSASQARE
>CV0625 tatC, Sec-independent protein translocase protein TatC
MNEQPLLAHLIELRTRLVRALLGIALVFLGLFHWSSDIYHLLAKPLLDAL
PQGGSMIATEVTSTFFVPMKVTMLVAFLISLPNTLYQIWAFVAPGLYSHE
KKLVLPLVLASLLLFLTGMAFAYFLVFPVVFHFMSAVTPAGVSMMTDIDK
YLSFVLGMFLAFGTTFEVPVLVVLLTRMGVVTVAKLREARPYVIVGAFVV
AAIVTPPDVLSQTLLAVPLWLLFEAGVLVAALLERKARAREQAESAP
>CV0109 tolB, TolB protein precursor
MPSLKTLLRGVLVAAMLVAGSARAELNIEIIGGGASRHAISVLPFKDEGP
TQGNLTPVIRNDLALSGAFRLIDPSAVANVPFEPADIRYPLWQAAGAQSL
AIGKVESAGGGQIKISFRLMDASQRKQLTGGEFTVTPDRSRQVAHAIADM
IYEAITGQKGFFNTRLAYVLKSGRSYALQISDVDGQRSQTILRSTEPIIS
PSWSPDGRHIAYVSFASQKPVVWVQDLATGQRRAVANFKGSNSAPAWSPD
GSKLAVVLTTSGNSQIYIINAAGGPARRLMYNGGIDTEPAFSPDGSMVYF
VSDRSGNPQIYRVPVNGGNAQRVTWEGAYNVSPKLSPDGKTLVYIRRSAG
NFRVMSQDLATNDSRQLSDGSYSERPSFAPNGRMVLYSSDAGGQSVLYAA
TADGSSKVKLAVLNGDVQDPAWGPFNNP
>CV0551 tolQ, tolQ-related transport transmembrane protein
MQQISFISLILNASLLVQLVMAGLALTSLLSWALIFNKISVLRSAKRHSE
EFERNFWSGADLNRLYEDVCRRSDTVGMERIFQSGFAEFLKLRGRSGAEL
SDIMDGSRRAMRAAAQRELDALDSHTSFLATVGSVSPYIGLFGTVWGIMH
AFIGLGNAGQATLSTVAPGIAEALVATAIGLFAAIPAVVAYNRFATDVDR
LATRFDTYMEEFSNILQRLATR
>CV0107 tolR, TolR protein
MLNRRPRRQMNQMNVVPYIDVMLVLLVIFMVTAPMFTPGVIDVPSVSEAP
AIDVRPLEVTVDAAGKIELVDGEQKTRVDSLDDLASQLQALAGAGARPVA
ISADANLKYAEVVRIADRLHQAGIKRVALTVKQISKQ
>CV4404 yidC, integral membrane protein, 60 kDa
MDSKRLIIFVLLSVGILFGWNEYFMPKHTPQQQAAKTQATTGAANNVAQP
ADANKLTRGQRIQVKTDLVEAEIDTVGGDLRSLKLLKHGAAEDHKQPFQL
FEDSAKRVYVAQTGLVAASNPALPTHKTVFTSDKPSYQLTGDTLEVKLTA
PDANGVKVSKVYTFKKNSYEIGVRYDIVNGGAAPLAPTAYYRLLRDSQAP
EGEGRMAHTYTGPAVYTSEHKFQKVSFDDLAKGKGDYAKTTTDGWVAMLQ
HYFMSAWILKPLDGASVCKDERSCRFELKETAGLNSAAALVDYATVAPGK
SLSVSVPLYAGPEEYNIISKLADGMEYAKDFGIFYIFASPLFWLLVKLHG
LVSNWGWAIVLLTLTVKAVFYPLTAASYRSMAKMKALAPRLERLKAQHGD
DRMKFQQAVMEMYKTEKVNPLGGCLPMLIQIPVFIGLYWALLASVELRGA
PWVLWYTDLARPDPYYILPVIMAATMFLQTFLNPPPADPMQAKMMKIMPL
AFSALFFFFPAGLVLYYVVNNVLSMAQQWFINKQIEKSNKAALQS